| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transmembrane transporter activity | ANO9 SCN11A CYBRD1 SLC2A7 FLVCR1 SIDT1 ANO1 ABCC5 MFSD4A SLC12A8 SLC46A1 SLC15A3 SLC7A6 SLC30A4 ABCA9 SLC1A6 SLC2A2 ABCB1 GJA9 SLC6A1 SLC38A1 SLC6A12 SLC7A1 SLC7A2 SLC9A1 SLC12A9 SLC26A7 SV2A SCN1A SLC7A5P2 SLC22A1 SCN2A SLC22A4 SCN3A SCN4A SCN5A SLC6A20 SCN8A SCN9A SV2C CACNA1I CACNA1H CTNS SLC5A12 SLC5A8 CNGA2 | 1.25e-27 | 1180 | 111 | 46 | GO:0022857 |
| GeneOntologyMolecularFunction | transporter activity | ANO9 SCN11A CYBRD1 SLC2A7 FLVCR1 SIDT1 ANO1 ABCC5 MFSD4A SLC12A8 SLC46A1 SLC15A3 SLC7A6 SLC30A4 ABCA9 SLC1A6 SLC2A2 ABCB1 GJA9 SLC6A1 SLC38A1 SLC6A12 SLC7A1 SLC7A2 SLC9A1 SLC12A9 SLC26A7 SV2A SCN1A SLC7A5P2 SLC22A1 SCN2A SLC22A4 SCN3A SCN4A SCN5A SLC6A20 SCN8A SCN9A SV2C CACNA1I CACNA1H CTNS SLC5A12 SLC5A8 CNGA2 | 5.44e-26 | 1289 | 111 | 46 | GO:0005215 |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | SCN11A SLC1A6 SLC6A1 SLC38A1 SLC6A12 SLC9A1 SCN1A SLC22A1 SCN2A SCN3A SCN4A SCN5A SLC6A20 SCN8A SCN9A CACNA1I CACNA1H SLC5A12 SLC5A8 | 1.12e-19 | 171 | 111 | 19 | GO:0015081 |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | ANO9 SCN11A ANO1 ABCC5 SLC12A8 SLC46A1 SLC15A3 SLC30A4 SLC1A6 SLC6A1 SLC38A1 SLC6A12 SLC9A1 SLC12A9 SLC26A7 SCN1A SLC22A1 SCN2A SCN3A SCN4A SCN5A SLC6A20 SCN8A SCN9A CACNA1I CACNA1H CTNS SLC5A12 SLC5A8 CNGA2 | 8.52e-18 | 758 | 111 | 30 | GO:0015318 |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | SCN11A SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A CACNA1I CACNA1H | 9.18e-17 | 26 | 111 | 10 | GO:0005248 |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | SCN11A ANO1 SLC12A8 SLC46A1 SLC15A3 SLC30A4 SLC1A6 SLC6A1 SLC38A1 SLC6A12 SLC9A1 SLC12A9 SCN1A SLC22A1 SCN2A SCN3A SCN4A SCN5A SLC6A20 SCN8A SCN9A CACNA1I CACNA1H CTNS SLC5A12 SLC5A8 CNGA2 | 2.58e-16 | 664 | 111 | 27 | GO:0008324 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | ANO9 SCN11A ANO1 SLC12A8 SLC46A1 SLC15A3 SLC30A4 SLC1A6 SLC6A1 SLC38A1 SLC6A12 SLC9A1 SLC12A9 SLC26A7 SCN1A SLC22A1 SCN2A SCN3A SCN4A SCN5A SLC6A20 SCN8A SCN9A CACNA1I CACNA1H CTNS SLC5A12 SLC5A8 CNGA2 | 2.70e-16 | 793 | 111 | 29 | GO:0015075 |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | SCN11A SLC12A8 SLC46A1 SLC15A3 SLC30A4 SLC1A6 SLC6A1 SLC38A1 SLC6A12 SLC9A1 SLC12A9 SCN1A SLC22A1 SCN2A SCN3A SCN4A SCN5A SLC6A20 SCN8A SCN9A CACNA1I CACNA1H CTNS SLC5A12 SLC5A8 CNGA2 | 6.35e-16 | 627 | 111 | 26 | GO:0022890 |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | SCN11A SLC12A8 SLC30A4 SLC1A6 SLC6A1 SLC38A1 SLC6A12 SLC9A1 SLC12A9 SCN1A SLC22A1 SCN2A SCN3A SCN4A SCN5A SLC6A20 SCN8A SCN9A CACNA1I CACNA1H SLC5A12 SLC5A8 CNGA2 | 8.99e-16 | 465 | 111 | 23 | GO:0046873 |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | CYBRD1 ABCC5 SLC12A8 SLC46A1 SLC15A3 SLC7A6 SLC30A4 ABCA9 SLC1A6 ABCB1 SLC6A1 SLC38A1 SLC6A12 SLC9A1 SLC12A9 SLC26A7 SLC22A1 SLC22A4 SLC6A20 CTNS SLC5A12 SLC5A8 | 1.72e-14 | 477 | 111 | 22 | GO:0022804 |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | SLC12A8 SLC46A1 SLC15A3 SLC7A6 SLC30A4 SLC1A6 SLC6A1 SLC38A1 SLC6A12 SLC9A1 SLC12A9 SLC26A7 SLC22A1 SLC22A4 SLC6A20 CTNS SLC5A12 SLC5A8 | 4.91e-14 | 296 | 111 | 18 | GO:0015291 |
| GeneOntologyMolecularFunction | symporter activity | SLC12A8 SLC46A1 SLC15A3 SLC1A6 SLC6A1 SLC38A1 SLC6A12 SLC12A9 SLC22A1 SLC22A4 SLC6A20 CTNS SLC5A12 SLC5A8 | 1.11e-13 | 150 | 111 | 14 | GO:0015293 |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | SLC12A8 SLC46A1 SLC15A3 SLC1A6 SLC6A1 SLC38A1 SLC6A12 SLC12A9 SLC22A1 SLC6A20 CTNS SLC5A12 SLC5A8 | 1.13e-13 | 119 | 111 | 13 | GO:0015294 |
| GeneOntologyMolecularFunction | sodium channel activity | SCN11A SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A CACNA1I CACNA1H | 2.42e-13 | 52 | 111 | 10 | GO:0005272 |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | ABCC5 SLC46A1 SLC7A6 SLC1A6 SLC2A2 ABCB1 SLC6A1 SLC38A1 SLC6A12 SLC7A1 SLC7A2 SLC26A7 SLC22A1 SLC6A20 CTNS SLC5A12 SLC5A8 | 5.63e-13 | 293 | 111 | 17 | GO:0008514 |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | SLC46A1 SLC7A6 SLC1A6 ABCB1 SLC6A1 SLC38A1 SLC6A12 SLC7A1 SLC7A2 SLC26A7 SLC6A20 CTNS SLC5A12 SLC5A8 | 9.25e-12 | 207 | 111 | 14 | GO:0046943 |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | SLC46A1 SLC7A6 SLC1A6 ABCB1 SLC6A1 SLC38A1 SLC6A12 SLC7A1 SLC7A2 SLC26A7 SLC6A20 CTNS SLC5A12 SLC5A8 | 9.87e-12 | 208 | 111 | 14 | GO:0005342 |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | SLC12A8 SLC46A1 SLC15A3 SLC1A6 SLC6A1 SLC38A1 SLC6A12 SLC9A1 SLC12A9 SLC26A7 SLC22A1 SLC6A20 CTNS SLC5A12 SLC5A8 | 1.23e-10 | 301 | 111 | 15 | GO:0022853 |
| GeneOntologyMolecularFunction | amino acid transmembrane transporter activity | SLC7A6 SLC1A6 SLC6A1 SLC38A1 SLC6A12 SLC7A1 SLC7A2 SLC22A4 SLC6A20 CTNS | 3.46e-10 | 105 | 111 | 10 | GO:0015171 |
| GeneOntologyMolecularFunction | organic acid:sodium symporter activity | 8.01e-10 | 35 | 111 | 7 | GO:0005343 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | GPR3 OR8D2 OR10J3 OR1C1 OR14C36 ACKR4 OR2T4 PTGER4 ADCYAP1R1 OPRK1 OR10G7 OR8A1 OR4C15 OR4A8 PROKR2 OR4A5 OR4A16 OR2A25 ADGRE1 OR13C7 OR8D4 OR4C5 | 2.85e-09 | 884 | 111 | 22 | GO:0004930 |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | GPR3 OR8D2 HLA-DQA2 OR10J3 OR1C1 OR14C36 ACKR4 OR2T4 PTGER4 ADCYAP1R1 OPRK1 OR10G7 OR8A1 TGFBR3 OR4C15 OR4A8 PROKR2 OR4A5 OR4A16 OR2A25 SEMA6A ADGRE1 OR13C7 OR8D4 KIT OR4C5 EPHA7 | 4.05e-09 | 1353 | 111 | 27 | GO:0004888 |
| GeneOntologyMolecularFunction | sodium ion binding | 9.32e-09 | 14 | 111 | 5 | GO:0031402 | |
| GeneOntologyMolecularFunction | solute:sodium symporter activity | SLC1A6 SLC6A1 SLC38A1 SLC6A12 SLC22A1 SLC6A20 SLC5A12 SLC5A8 | 1.62e-08 | 81 | 111 | 8 | GO:0015370 |
| GeneOntologyMolecularFunction | olfactory receptor activity | OR8D2 OR10J3 OR1C1 OR14C36 OR2T4 OR10G7 OR8A1 OR4C15 OR4A8 OR4A5 OR4A16 OR2A25 OR13C7 OR8D4 OR4C5 | 1.66e-08 | 431 | 111 | 15 | GO:0004984 |
| GeneOntologyMolecularFunction | modified amino acid transmembrane transporter activity | 2.52e-08 | 33 | 111 | 6 | GO:0072349 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | ANO9 SCN11A ANO1 GJA9 SLC26A7 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A CACNA1I CACNA1H SLC5A8 CNGA2 | 3.48e-08 | 526 | 111 | 16 | GO:0022803 |
| GeneOntologyMolecularFunction | L-amino acid transmembrane transporter activity | 1.34e-07 | 71 | 111 | 7 | GO:0015179 | |
| GeneOntologyMolecularFunction | chloride:monoatomic cation symporter activity | 1.51e-07 | 23 | 111 | 5 | GO:0015377 | |
| GeneOntologyMolecularFunction | amino acid:sodium symporter activity | 1.51e-07 | 23 | 111 | 5 | GO:0005283 | |
| GeneOntologyMolecularFunction | monoatomic anion transmembrane transporter activity | ANO9 ANO1 SLC12A8 SLC1A6 SLC6A1 SLC6A12 SLC12A9 SLC26A7 SLC22A1 | 1.67e-07 | 151 | 111 | 9 | GO:0008509 |
| GeneOntologyMolecularFunction | channel activity | ANO9 SCN11A ANO1 GJA9 SLC26A7 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A CACNA1I CACNA1H CNGA2 | 2.17e-07 | 525 | 111 | 15 | GO:0015267 |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | ANO9 SCN11A ANO1 SLC26A7 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A CACNA1I CACNA1H CNGA2 | 2.60e-07 | 459 | 111 | 14 | GO:0005216 |
| GeneOntologyMolecularFunction | alkali metal ion binding | 2.91e-07 | 26 | 111 | 5 | GO:0031420 | |
| GeneOntologyMolecularFunction | monoatomic anion:monoatomic cation symporter activity | 2.91e-07 | 26 | 111 | 5 | GO:0015296 | |
| GeneOntologyMolecularFunction | organic cation transmembrane transporter activity | 3.97e-07 | 83 | 111 | 7 | GO:0015101 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | SCN11A ANO1 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A CACNA1I CACNA1H CNGA2 | 4.68e-07 | 343 | 111 | 12 | GO:0005261 |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | ANO9 ANO1 ABCC5 SLC12A8 SLC6A1 SLC6A12 SLC12A9 SLC26A7 SLC22A1 | 4.80e-07 | 171 | 111 | 9 | GO:0015103 |
| GeneOntologyMolecularFunction | chloride transmembrane transporter activity | 4.85e-07 | 125 | 111 | 8 | GO:0015108 | |
| GeneOntologyMolecularFunction | amino acid:monoatomic cation symporter activity | 5.18e-07 | 29 | 111 | 5 | GO:0005416 | |
| GeneOntologyMolecularFunction | monocarboxylate:sodium symporter activity | 1.18e-06 | 15 | 111 | 4 | GO:0140161 | |
| GeneOntologyMolecularFunction | secondary active monocarboxylate transmembrane transporter activity | 3.29e-06 | 19 | 111 | 4 | GO:0015355 | |
| GeneOntologyMolecularFunction | heme transmembrane transporter activity | 1.37e-05 | 9 | 111 | 3 | GO:0015232 | |
| GeneOntologyMolecularFunction | L-lysine transmembrane transporter activity | 1.37e-05 | 9 | 111 | 3 | GO:0015189 | |
| GeneOntologyMolecularFunction | secondary active organic cation transmembrane transporter activity | 3.06e-05 | 2 | 111 | 2 | GO:0008513 | |
| GeneOntologyMolecularFunction | xenobiotic transmembrane transporter activity | 3.69e-05 | 34 | 111 | 4 | GO:0042910 | |
| GeneOntologyMolecularFunction | L-arginine transmembrane transporter activity | 4.59e-05 | 13 | 111 | 3 | GO:0061459 | |
| GeneOntologyMolecularFunction | quaternary ammonium group transmembrane transporter activity | 7.25e-05 | 15 | 111 | 3 | GO:0015651 | |
| GeneOntologyMolecularFunction | odorant binding | 7.71e-05 | 127 | 111 | 6 | GO:0005549 | |
| GeneOntologyMolecularFunction | low voltage-gated calcium channel activity | 9.15e-05 | 3 | 111 | 2 | GO:0008332 | |
| GeneOntologyMolecularFunction | sodium:chloride symporter activity | 1.07e-04 | 17 | 111 | 3 | GO:0015378 | |
| GeneOntologyMolecularFunction | monoatomic anion:sodium symporter activity | 1.52e-04 | 19 | 111 | 3 | GO:0015373 | |
| GeneOntologyMolecularFunction | basic amino acid transmembrane transporter activity | 1.78e-04 | 20 | 111 | 3 | GO:0015174 | |
| GeneOntologyMolecularFunction | acetate ester transmembrane transporter activity | 1.82e-04 | 4 | 111 | 2 | GO:1901375 | |
| GeneOntologyMolecularFunction | amino-acid betaine transmembrane transporter activity | 1.82e-04 | 4 | 111 | 2 | GO:0015199 | |
| GeneOntologyMolecularFunction | acetylcholine transmembrane transporter activity | 1.82e-04 | 4 | 111 | 2 | GO:0005277 | |
| GeneOntologyMolecularFunction | L-ornithine transmembrane transporter activity | 3.03e-04 | 5 | 111 | 2 | GO:0000064 | |
| GeneOntologyMolecularFunction | proline:sodium symporter activity | 3.03e-04 | 5 | 111 | 2 | GO:0005298 | |
| GeneOntologyMolecularFunction | hexose transmembrane transporter activity | 3.52e-04 | 25 | 111 | 3 | GO:0015149 | |
| GeneOntologyMolecularFunction | solute:proton symporter activity | 3.52e-04 | 25 | 111 | 3 | GO:0015295 | |
| GeneOntologyMolecularFunction | D-glucose transmembrane transporter activity | 3.52e-04 | 25 | 111 | 3 | GO:0055056 | |
| GeneOntologyMolecularFunction | sulfur compound transmembrane transporter activity | 3.70e-04 | 61 | 111 | 4 | GO:1901682 | |
| GeneOntologyMolecularFunction | monosaccharide transmembrane transporter activity | 4.44e-04 | 27 | 111 | 3 | GO:0015145 | |
| GeneOntologyMolecularFunction | carnitine transmembrane transporter activity | 4.53e-04 | 6 | 111 | 2 | GO:0015226 | |
| GeneOntologyMolecularFunction | gamma-aminobutyric acid:sodium:chloride symporter activity | 4.53e-04 | 6 | 111 | 2 | GO:0005332 | |
| GeneOntologyMolecularFunction | lactate transmembrane transporter activity | 4.53e-04 | 6 | 111 | 2 | GO:0015129 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 5.42e-04 | 182 | 111 | 6 | GO:0005244 | |
| GeneOntologyMolecularFunction | sugar transmembrane transporter activity | 5.50e-04 | 29 | 111 | 3 | GO:0051119 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 5.74e-04 | 184 | 111 | 6 | GO:0022832 | |
| GeneOntologyMolecularFunction | dicarboxylic acid transmembrane transporter activity | 6.71e-04 | 31 | 111 | 3 | GO:0005310 | |
| GeneOntologyMolecularFunction | lipid transporter activity | 7.99e-04 | 196 | 111 | 6 | GO:0005319 | |
| GeneOntologyMolecularFunction | macromolecule transmembrane transporter activity | 8.82e-04 | 34 | 111 | 3 | GO:0022884 | |
| GeneOntologyMolecularFunction | vitamin transmembrane transporter activity | 1.04e-03 | 36 | 111 | 3 | GO:0090482 | |
| GeneOntologyMolecularFunction | fructose transmembrane transporter activity | 1.07e-03 | 9 | 111 | 2 | GO:0005353 | |
| GeneOntologyMolecularFunction | potassium:chloride symporter activity | 1.07e-03 | 9 | 111 | 2 | GO:0015379 | |
| GeneOntologyMolecularFunction | gamma-aminobutyric acid transmembrane transporter activity | 1.07e-03 | 9 | 111 | 2 | GO:0015185 | |
| GeneOntologyMolecularFunction | neutral L-amino acid transmembrane transporter activity | 1.53e-03 | 41 | 111 | 3 | GO:0015175 | |
| GeneOntologyMolecularFunction | monocarboxylic acid transmembrane transporter activity | 1.60e-03 | 90 | 111 | 4 | GO:0008028 | |
| GeneOntologyMolecularFunction | carbohydrate transmembrane transporter activity | 1.64e-03 | 42 | 111 | 3 | GO:0015144 | |
| GeneOntologyMolecularFunction | amide transmembrane transporter activity | 1.64e-03 | 42 | 111 | 3 | GO:0042887 | |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 2.56e-03 | 49 | 111 | 3 | GO:0140359 | |
| GeneOntologyMolecularFunction | gated channel activity | 2.65e-03 | 334 | 111 | 7 | GO:0022836 | |
| GeneOntologyMolecularFunction | azole transmembrane transporter activity | 2.67e-03 | 14 | 111 | 2 | GO:1901474 | |
| GeneOntologyMolecularFunction | high voltage-gated calcium channel activity | 2.67e-03 | 14 | 111 | 2 | GO:0008331 | |
| GeneOntologyMolecularFunction | intramembrane lipid transporter activity | 2.87e-03 | 51 | 111 | 3 | GO:0140303 | |
| GeneOntologyMolecularFunction | ABC-type xenobiotic transporter activity | 3.07e-03 | 15 | 111 | 2 | GO:0008559 | |
| GeneOntologyMolecularFunction | efflux transmembrane transporter activity | 3.49e-03 | 16 | 111 | 2 | GO:0015562 | |
| GeneOntologyMolecularFunction | oligopeptide transmembrane transporter activity | 3.49e-03 | 16 | 111 | 2 | GO:0035673 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential | 3.94e-03 | 17 | 111 | 2 | GO:0099508 | |
| GeneOntologyMolecularFunction | carbohydrate derivative transmembrane transporter activity | 4.33e-03 | 59 | 111 | 3 | GO:1901505 | |
| GeneOntologyMolecularFunction | nucleobase-containing compound transmembrane transporter activity | 4.33e-03 | 59 | 111 | 3 | GO:0015932 | |
| GeneOntologyMolecularFunction | intracellularly calcium-gated channel activity | 5.45e-03 | 20 | 111 | 2 | GO:0141147 | |
| GeneOntologyMolecularFunction | intracellularly calcium-gated chloride channel activity | 5.45e-03 | 20 | 111 | 2 | GO:0005229 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | ANO9 SCN11A CYBRD1 FLVCR1 ANO1 ABCC5 SLC12A8 SLC46A1 SLC15A3 SLC30A4 SLC1A6 ADCYAP1R1 OPRK1 ABCB1 SLC6A1 SLC38A1 SLC6A12 SLC9A1 SLC12A9 SLC26A7 SCN1A SLC22A1 SCN2A SLC22A4 SCN3A SCN4A SCN5A SLC6A20 SCN8A SCN9A CACNA1I CACNA1H CTNS SLC5A12 SLC5A8 CNGA2 | 2.97e-16 | 1374 | 110 | 36 | GO:0006811 |
| GeneOntologyBiologicalProcess | sodium ion transport | SCN11A SLC6A1 SLC38A1 SLC6A12 SLC9A1 SCN1A SCN2A SLC22A4 SCN3A SCN4A SCN5A SLC6A20 SCN8A SCN9A CACNA1I CACNA1H SLC5A12 SLC5A8 CNGA2 | 4.13e-16 | 275 | 110 | 19 | GO:0006814 |
| GeneOntologyBiologicalProcess | membrane depolarization during action potential | SCN11A SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A CACNA1I CACNA1H | 2.77e-15 | 36 | 110 | 10 | GO:0086010 |
| GeneOntologyBiologicalProcess | monoatomic cation transport | SCN11A CYBRD1 FLVCR1 ANO1 ABCC5 SLC12A8 SLC46A1 SLC15A3 SLC30A4 ADCYAP1R1 OPRK1 SLC6A1 SLC38A1 SLC6A12 SLC9A1 SLC12A9 SCN1A SLC22A1 SCN2A SLC22A4 SCN3A SCN4A SCN5A SLC6A20 SCN8A SCN9A CACNA1I CACNA1H CTNS SLC5A12 SLC5A8 CNGA2 | 4.69e-15 | 1157 | 110 | 32 | GO:0006812 |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | ANO9 SCN11A ANO1 ABCC5 SLC12A8 SLC46A1 SLC15A3 SLC30A4 ADCYAP1R1 OPRK1 SLC6A1 SLC38A1 SLC6A12 SLC9A1 SLC12A9 SLC26A7 SCN1A SCN2A SCN3A SCN4A SCN5A SLC6A20 SCN8A SCN9A CACNA1I CACNA1H CTNS SLC5A8 CNGA2 | 5.62e-14 | 1017 | 110 | 29 | GO:0098660 |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | ANO9 SCN11A ANO1 ABCC5 SLC12A8 SLC46A1 SLC15A3 SLC30A4 ADCYAP1R1 OPRK1 ABCB1 SLC6A1 SLC38A1 SLC6A12 SLC9A1 SLC12A9 SLC26A7 SCN1A SLC22A1 SCN2A SCN3A SCN4A SCN5A SLC6A20 SCN8A SCN9A CACNA1I CACNA1H CTNS CNGA2 | 8.50e-14 | 1115 | 110 | 30 | GO:0034220 |
| GeneOntologyBiologicalProcess | carboxylic acid transmembrane transport | ARL6IP5 ABCC5 SLC46A1 SLC7A6 SLC1A6 ABCB1 SLC38A1 SLC7A1 SLC7A2 SLC26A7 SLC7A5P2 SLC6A20 SLC5A12 SLC5A8 | 2.01e-13 | 163 | 110 | 14 | GO:1905039 |
| GeneOntologyBiologicalProcess | metal ion transport | SCN11A CYBRD1 FLVCR1 ABCC5 SLC12A8 SLC46A1 SLC30A4 ADCYAP1R1 OPRK1 SLC6A1 SLC38A1 SLC6A12 SLC9A1 SLC12A9 SCN1A SCN2A SLC22A4 SCN3A SCN4A SCN5A SLC6A20 SCN8A SCN9A CACNA1I CACNA1H SLC5A12 SLC5A8 CNGA2 | 2.62e-13 | 1000 | 110 | 28 | GO:0030001 |
| GeneOntologyBiologicalProcess | organic acid transmembrane transport | ARL6IP5 ABCC5 SLC46A1 SLC7A6 SLC1A6 ABCB1 SLC38A1 SLC7A1 SLC7A2 SLC26A7 SLC7A5P2 SLC6A20 SLC5A12 SLC5A8 | 2.81e-13 | 167 | 110 | 14 | GO:1903825 |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | SCN11A SLC6A1 SLC38A1 SLC6A12 SLC9A1 SCN1A SCN2A SCN3A SCN4A SCN5A SLC6A20 SCN8A SCN9A CACNA1I CACNA1H | 3.46e-13 | 208 | 110 | 15 | GO:0035725 |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | SCN11A ANO1 ABCC5 SLC12A8 SLC46A1 SLC15A3 SLC30A4 ADCYAP1R1 OPRK1 SLC6A1 SLC38A1 SLC6A12 SLC9A1 SLC12A9 SCN1A SLC22A1 SCN2A SCN3A SCN4A SCN5A SLC6A20 SCN8A SCN9A CACNA1I CACNA1H CTNS CNGA2 | 4.42e-13 | 942 | 110 | 27 | GO:0098655 |
| GeneOntologyBiologicalProcess | carboxylic acid transport | ARL6IP5 ABCC5 SLC46A1 SLC7A6 SLC1A6 ABCB1 SLC6A1 SLC38A1 SLC6A12 SLC7A1 SLC7A2 SLC26A7 SV2A SLC7A5P2 SLC22A1 SLC6A20 CTNS SLC5A12 SLC5A8 | 5.69e-13 | 410 | 110 | 19 | GO:0046942 |
| GeneOntologyBiologicalProcess | organic acid transport | ARL6IP5 ABCC5 SLC46A1 SLC7A6 SLC1A6 ABCB1 SLC6A1 SLC38A1 SLC6A12 SLC7A1 SLC7A2 SLC26A7 SV2A SLC7A5P2 SLC22A1 SLC6A20 CTNS SLC5A12 SLC5A8 | 6.20e-13 | 412 | 110 | 19 | GO:0015849 |
| GeneOntologyBiologicalProcess | neuronal action potential | SCN11A SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A CACNA1I CACNA1H | 1.24e-12 | 63 | 110 | 10 | GO:0019228 |
| GeneOntologyBiologicalProcess | import across plasma membrane | ARL6IP5 SLC12A8 SLC46A1 SLC15A3 SLC1A6 SLC6A1 SLC38A1 SLC7A1 SLC7A2 SLC9A1 SLC22A4 SCN5A SLC6A20 CACNA1I CACNA1H | 1.49e-12 | 230 | 110 | 15 | GO:0098739 |
| GeneOntologyBiologicalProcess | organic anion transport | ARL6IP5 ABCC5 SLC46A1 SLC7A6 SLC1A6 SLC2A2 ABCB1 SLC6A1 SLC38A1 SLC6A12 SLC7A1 SLC7A2 SLC26A7 SV2A SLC7A5P2 SLC22A1 SLC6A20 CTNS SLC5A12 SLC5A8 | 3.37e-12 | 515 | 110 | 20 | GO:0015711 |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | SCN11A ABCC5 SLC12A8 SLC46A1 SLC15A3 SLC30A4 ADCYAP1R1 OPRK1 SLC6A1 SLC38A1 SLC6A12 SLC9A1 SLC12A9 SCN1A SCN2A SCN3A SCN4A SCN5A SLC6A20 SCN8A SCN9A CACNA1I CACNA1H CTNS CNGA2 | 1.27e-11 | 922 | 110 | 25 | GO:0098662 |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception | SCN11A OR8D2 OR10J3 ANO1 OR1C1 OR14C36 OR2T4 OR10G7 OR8A1 OR4C15 OR4A8 OR4A5 OR4A16 SCN1A SCN9A OR2A25 OR13C7 OR8D4 KIT OR4C5 | 3.06e-11 | 582 | 110 | 20 | GO:0050906 |
| GeneOntologyBiologicalProcess | amino acid transport | ARL6IP5 SLC7A6 SLC1A6 SLC6A1 SLC38A1 SLC6A12 SLC7A1 SLC7A2 SV2A SLC7A5P2 SLC22A4 SLC6A20 CTNS | 3.84e-11 | 195 | 110 | 13 | GO:0006865 |
| GeneOntologyBiologicalProcess | membrane depolarization | SCN11A SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A CACNA1I CACNA1H CNGA2 | 4.66e-11 | 121 | 110 | 11 | GO:0051899 |
| GeneOntologyBiologicalProcess | cardiac muscle cell contraction | SCN11A SLC9A1 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A CACNA1H | 6.85e-11 | 93 | 110 | 10 | GO:0086003 |
| GeneOntologyBiologicalProcess | modified amino acid transport | 7.64e-11 | 44 | 110 | 8 | GO:0072337 | |
| GeneOntologyBiologicalProcess | detection of stimulus | SCN11A OR8D2 OR10J3 ANO1 OR1C1 OR14C36 OR2T4 OR10G7 OR8A1 CADM1 OR4C15 OR4A8 OR4A5 OR4A16 SCN1A SCN9A OR2A25 OR13C7 OR8D4 KIT OR4C5 | 2.01e-10 | 722 | 110 | 21 | GO:0051606 |
| GeneOntologyBiologicalProcess | transmission of nerve impulse | SCN11A SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A CACNA1I CACNA1H | 4.41e-10 | 112 | 110 | 10 | GO:0019226 |
| GeneOntologyBiologicalProcess | amino acid transmembrane transport | ARL6IP5 SLC7A6 SLC1A6 SLC38A1 SLC6A12 SLC7A1 SLC7A2 SLC7A5P2 SLC22A4 SLC6A20 | 8.73e-10 | 120 | 110 | 10 | GO:0003333 |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential involved in contraction | 1.35e-09 | 62 | 110 | 8 | GO:0086002 | |
| GeneOntologyBiologicalProcess | actin-mediated cell contraction | SCN11A SLC9A1 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A CACNA1H | 1.53e-09 | 127 | 110 | 10 | GO:0070252 |
| GeneOntologyBiologicalProcess | sensory perception of smell | OR8D2 OR10J3 OR1C1 OR14C36 OR2T4 OR10G7 OR8A1 OR4C15 OR4A8 OR4A5 OR4A16 OR2A25 OR13C7 OR8D4 CNGA2 OR4C5 | 3.45e-09 | 465 | 110 | 16 | GO:0007608 |
| GeneOntologyBiologicalProcess | L-amino acid transport | ARL6IP5 SLC7A6 SLC1A6 SLC38A1 SLC7A1 SLC7A2 SLC7A5P2 SLC6A20 CTNS | 6.31e-09 | 108 | 110 | 9 | GO:0015807 |
| GeneOntologyBiologicalProcess | amino-acid betaine transport | 7.58e-09 | 14 | 110 | 5 | GO:0015838 | |
| GeneOntologyBiologicalProcess | sensory perception | SCN11A OR8D2 OR10J3 ANO1 OR1C1 OR14C36 OR2T4 OPRK1 OR10G7 OR8A1 OR4C15 OR4A8 OR4A5 OR4A16 SCN1A SCN8A SCN9A OR2A25 OR13C7 OR8D4 KIT CNGA2 OR4C5 | 8.79e-09 | 1072 | 110 | 23 | GO:0007600 |
| GeneOntologyBiologicalProcess | actin filament-based movement | SCN11A SLC9A1 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A CACNA1H | 9.33e-09 | 153 | 110 | 10 | GO:0030048 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of smell | OR8D2 OR10J3 OR1C1 OR14C36 OR2T4 OR10G7 OR8A1 OR4C15 OR4A8 OR4A5 OR4A16 OR2A25 OR13C7 OR8D4 OR4C5 | 9.84e-09 | 432 | 110 | 15 | GO:0050911 |
| GeneOntologyBiologicalProcess | action potential | SCN11A SLC9A1 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A CACNA1I CACNA1H | 1.05e-08 | 201 | 110 | 11 | GO:0001508 |
| GeneOntologyBiologicalProcess | circulatory system process | SCN11A ABCC5 ABCB1 SLC6A1 SLC38A1 TGFBR3 SLC7A1 SLC7A2 SLC9A1 SCN1A SLC22A1 SCN2A SCN3A SCN4A SCN5A SLC6A20 SCN8A SCN9A CACNA1H | 1.07e-08 | 733 | 110 | 19 | GO:0003013 |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential | 2.08e-08 | 87 | 110 | 8 | GO:0086001 | |
| GeneOntologyBiologicalProcess | L-alpha-amino acid transmembrane transport | ARL6IP5 SLC7A6 SLC1A6 SLC38A1 SLC7A1 SLC7A2 SLC7A5P2 SLC6A20 | 2.08e-08 | 87 | 110 | 8 | GO:1902475 |
| GeneOntologyBiologicalProcess | transport across blood-brain barrier | 2.08e-08 | 87 | 110 | 8 | GO:0150104 | |
| GeneOntologyBiologicalProcess | cardiac muscle contraction | SCN11A SLC9A1 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A CACNA1H | 2.16e-08 | 167 | 110 | 10 | GO:0060048 |
| GeneOntologyBiologicalProcess | vascular transport | 2.28e-08 | 88 | 110 | 8 | GO:0010232 | |
| GeneOntologyBiologicalProcess | amino acid import across plasma membrane | 2.43e-08 | 58 | 110 | 7 | GO:0089718 | |
| GeneOntologyBiologicalProcess | sensory perception of chemical stimulus | OR8D2 OR10J3 OR1C1 OR14C36 OR2T4 OR10G7 OR8A1 OR4C15 OR4A8 OR4A5 OR4A16 OR2A25 OR13C7 OR8D4 CNGA2 OR4C5 | 3.37e-08 | 547 | 110 | 16 | GO:0007606 |
| GeneOntologyBiologicalProcess | quaternary ammonium group transport | 4.31e-08 | 19 | 110 | 5 | GO:0015697 | |
| GeneOntologyBiologicalProcess | regulation of membrane potential | SCN11A ARL6IP5 ANO1 SLC1A6 SLC9A1 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A CACNA1I CACNA1H CTNS CNGA2 | 4.55e-08 | 559 | 110 | 16 | GO:0042391 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception | OR8D2 OR10J3 OR1C1 OR14C36 OR2T4 OR10G7 OR8A1 OR4C15 OR4A8 OR4A5 OR4A16 OR2A25 OR13C7 OR8D4 OR4C5 | 4.55e-08 | 485 | 110 | 15 | GO:0050907 |
| GeneOntologyBiologicalProcess | organic cation transport | SLC7A6 SLC38A1 SLC6A12 SLC7A1 SLC7A2 SLC22A1 SLC22A4 SCN4A SLC6A20 | 8.30e-08 | 145 | 110 | 9 | GO:0015695 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus | OR8D2 OR10J3 OR1C1 OR14C36 OR2T4 OR10G7 OR8A1 OR4C15 OR4A8 OR4A5 OR4A16 OR2A25 OR13C7 OR8D4 OR4C5 | 1.24e-07 | 524 | 110 | 15 | GO:0009593 |
| GeneOntologyBiologicalProcess | striated muscle contraction | SCN11A SLC9A1 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A CACNA1H | 2.53e-07 | 217 | 110 | 10 | GO:0006941 |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | GPR3 SCN11A OR8D2 OR10J3 ANO1 OR1C1 OR14C36 ACKR4 OR2T4 PTGER4 ADCYAP1R1 OPRK1 OR10G7 OR8A1 OR4C15 OR4A8 PROKR2 OR4A5 OR4A16 OR2A25 ADGRE1 OR13C7 OR8D4 OR4C5 | 2.57e-07 | 1395 | 110 | 24 | GO:0007186 |
| GeneOntologyBiologicalProcess | neurotransmitter uptake | 3.34e-07 | 52 | 110 | 6 | GO:0001504 | |
| GeneOntologyBiologicalProcess | chloride transport | 4.26e-07 | 128 | 110 | 8 | GO:0006821 | |
| GeneOntologyBiologicalProcess | monoatomic anion transport | 6.02e-07 | 183 | 110 | 9 | GO:0006820 | |
| GeneOntologyBiologicalProcess | neurotransmitter transport | ARL6IP5 PTGER4 SLC1A6 SLC6A1 SLC38A1 SLC6A12 SV2A SLC22A1 SLC22A4 SV2C | 1.28e-06 | 259 | 110 | 10 | GO:0006836 |
| GeneOntologyBiologicalProcess | muscle contraction | SCN11A PTGER4 SLC9A1 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A CACNA1H KIT | 1.53e-06 | 400 | 110 | 12 | GO:0006936 |
| GeneOntologyBiologicalProcess | monoatomic anion transmembrane transport | 1.65e-06 | 153 | 110 | 8 | GO:0098656 | |
| GeneOntologyBiologicalProcess | small intestine smooth muscle contraction | 2.92e-06 | 6 | 110 | 3 | GO:1990770 | |
| GeneOntologyBiologicalProcess | heart contraction | SCN11A SLC9A1 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A CACNA1H | 4.47e-06 | 298 | 110 | 10 | GO:0060047 |
| GeneOntologyBiologicalProcess | ornithine transport | 5.09e-06 | 7 | 110 | 3 | GO:0015822 | |
| GeneOntologyBiologicalProcess | inorganic anion transport | 5.53e-06 | 180 | 110 | 8 | GO:0015698 | |
| GeneOntologyBiologicalProcess | heart process | SCN11A SLC9A1 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A CACNA1H | 6.16e-06 | 309 | 110 | 10 | GO:0003015 |
| GeneOntologyBiologicalProcess | inorganic anion transmembrane transport | 7.61e-06 | 134 | 110 | 7 | GO:0098661 | |
| GeneOntologyBiologicalProcess | heme transport | 1.21e-05 | 9 | 110 | 3 | GO:0015886 | |
| GeneOntologyBiologicalProcess | detection of mechanical stimulus involved in sensory perception | 1.32e-05 | 57 | 110 | 5 | GO:0050974 | |
| GeneOntologyBiologicalProcess | import into cell | ARL6IP5 SLC12A8 SLC46A1 SLC15A3 SLC1A6 SLC6A1 SLC38A1 SLC6A12 SLC7A1 SLC7A2 SLC9A1 SLC22A1 SLC22A4 SCN5A SLC6A20 CACNA1I CACNA1H CD151 | 1.45e-05 | 1074 | 110 | 18 | GO:0098657 |
| GeneOntologyBiologicalProcess | neutral amino acid transport | 1.70e-05 | 60 | 110 | 5 | GO:0015804 | |
| GeneOntologyBiologicalProcess | L-lysine transmembrane transport | 1.72e-05 | 10 | 110 | 3 | GO:1903401 | |
| GeneOntologyBiologicalProcess | L-lysine transport | 1.72e-05 | 10 | 110 | 3 | GO:1902022 | |
| GeneOntologyBiologicalProcess | intestine smooth muscle contraction | 1.72e-05 | 10 | 110 | 3 | GO:0014827 | |
| GeneOntologyBiologicalProcess | iodide transport | 2.36e-05 | 11 | 110 | 3 | GO:0015705 | |
| GeneOntologyBiologicalProcess | chloride transmembrane transport | 3.03e-05 | 112 | 110 | 6 | GO:1902476 | |
| GeneOntologyBiologicalProcess | iron coordination entity transport | 3.14e-05 | 12 | 110 | 3 | GO:1901678 | |
| GeneOntologyBiologicalProcess | muscle system process | SCN11A PTGER4 SLC9A1 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A CACNA1H KIT | 3.56e-05 | 547 | 110 | 12 | GO:0003012 |
| GeneOntologyBiologicalProcess | sensory perception of temperature stimulus | 4.92e-05 | 38 | 110 | 4 | GO:0050951 | |
| GeneOntologyBiologicalProcess | detection of mechanical stimulus | 5.05e-05 | 75 | 110 | 5 | GO:0050982 | |
| GeneOntologyBiologicalProcess | L-arginine transmembrane transport | 6.41e-05 | 15 | 110 | 3 | GO:1903826 | |
| GeneOntologyBiologicalProcess | gastro-intestinal system smooth muscle contraction | 6.41e-05 | 15 | 110 | 3 | GO:0014831 | |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception of pain | 8.05e-05 | 43 | 110 | 4 | GO:0062149 | |
| GeneOntologyBiologicalProcess | nitrate import | 8.43e-05 | 3 | 110 | 2 | GO:1902025 | |
| GeneOntologyBiologicalProcess | nitrate transmembrane transport | 8.43e-05 | 3 | 110 | 2 | GO:0015706 | |
| GeneOntologyBiologicalProcess | glycine betaine transport | 8.43e-05 | 3 | 110 | 2 | GO:0031460 | |
| GeneOntologyBiologicalProcess | vascular process in circulatory system | ABCC5 ABCB1 SLC6A1 SLC38A1 TGFBR3 SLC7A1 SLC7A2 SLC22A1 SLC6A20 | 9.52e-05 | 344 | 110 | 9 | GO:0003018 |
| GeneOntologyBiologicalProcess | inorganic ion import across plasma membrane | 1.14e-04 | 142 | 110 | 6 | GO:0099587 | |
| GeneOntologyBiologicalProcess | inorganic cation import across plasma membrane | 1.14e-04 | 142 | 110 | 6 | GO:0098659 | |
| GeneOntologyBiologicalProcess | basic amino acid transmembrane transport | 1.34e-04 | 19 | 110 | 3 | GO:1990822 | |
| GeneOntologyBiologicalProcess | response to toxic substance | 1.61e-04 | 289 | 110 | 8 | GO:0009636 | |
| GeneOntologyBiologicalProcess | gamma-aminobutyric acid reuptake | 1.68e-04 | 4 | 110 | 2 | GO:0051936 | |
| GeneOntologyBiologicalProcess | basic amino acid transport | 2.11e-04 | 22 | 110 | 3 | GO:0015802 | |
| GeneOntologyBiologicalProcess | vitamin transport | 2.27e-04 | 56 | 110 | 4 | GO:0051180 | |
| GeneOntologyBiologicalProcess | positive regulation of cAMP-mediated signaling | 2.42e-04 | 23 | 110 | 3 | GO:0043950 | |
| GeneOntologyBiologicalProcess | vitamin transmembrane transport | 2.42e-04 | 23 | 110 | 3 | GO:0035461 | |
| GeneOntologyBiologicalProcess | sensory perception of pain | 2.49e-04 | 105 | 110 | 5 | GO:0019233 | |
| GeneOntologyBiologicalProcess | regulation of small intestine smooth muscle contraction | 2.79e-04 | 5 | 110 | 2 | GO:1904347 | |
| GeneOntologyBiologicalProcess | folate transmembrane transport | 2.79e-04 | 5 | 110 | 2 | GO:0098838 | |
| GeneOntologyBiologicalProcess | behavioral response to chemical pain | 2.79e-04 | 5 | 110 | 2 | GO:0061366 | |
| GeneOntologyBiologicalProcess | behavioral response to formalin induced pain | 2.79e-04 | 5 | 110 | 2 | GO:0061368 | |
| GeneOntologyBiologicalProcess | regulation of amino acid transport | 2.97e-04 | 60 | 110 | 4 | GO:0051955 | |
| GeneOntologyBiologicalProcess | transition metal ion transport | 3.50e-04 | 113 | 110 | 5 | GO:0000041 | |
| GeneOntologyBiologicalProcess | response to prostaglandin E | 3.51e-04 | 26 | 110 | 3 | GO:0034695 | |
| GeneOntologyBiologicalProcess | detection of mechanical stimulus involved in sensory perception of pain | 3.51e-04 | 26 | 110 | 3 | GO:0050966 | |
| GeneOntologyBiologicalProcess | detection of temperature stimulus involved in sensory perception of pain | 3.51e-04 | 26 | 110 | 3 | GO:0050965 | |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | SCN11A SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A CACNA1I CACNA1H | 2.22e-19 | 17 | 111 | 10 | GO:0001518 |
| GeneOntologyCellularComponent | sodium channel complex | SCN11A SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A CACNA1I CACNA1H | 2.17e-16 | 29 | 111 | 10 | GO:0034706 |
| GeneOntologyCellularComponent | apical plasma membrane | CYBRD1 SLC2A7 ANO1 ABCC5 SLC46A1 SLC2A2 ABCB1 SLC38A1 SLC7A1 SLC9A1 SLC26A7 SLC22A1 SLC22A4 SLC6A20 SLC5A12 SLC5A8 | 6.30e-09 | 487 | 111 | 16 | GO:0016324 |
| GeneOntologyCellularComponent | cation channel complex | SCN11A SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A CACNA1I CACNA1H CNGA2 | 5.06e-08 | 235 | 111 | 11 | GO:0034703 |
| GeneOntologyCellularComponent | apical part of cell | CYBRD1 SLC2A7 ANO1 ABCC5 SLC46A1 SLC2A2 ABCB1 SLC38A1 SLC7A1 SLC9A1 SLC26A7 SLC22A1 SLC22A4 SLC6A20 SLC5A12 SLC5A8 | 9.48e-08 | 592 | 111 | 16 | GO:0045177 |
| GeneOntologyCellularComponent | monoatomic ion channel complex | SCN11A ANO1 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A CACNA1I CACNA1H CNGA2 | 8.11e-07 | 378 | 111 | 12 | GO:0034702 |
| GeneOntologyCellularComponent | presynaptic membrane | SCN11A ANO1 SLC1A6 OPRK1 SLC6A1 CADM1 SCN1A SCN2A SCN8A CACNA1H | 2.26e-06 | 277 | 111 | 10 | GO:0042734 |
| GeneOntologyCellularComponent | basal plasma membrane | ABCC5 SLC46A1 SLC2A2 SLC38A1 SLC6A12 SLC7A1 SLC9A1 CADM1 SLC26A7 SLC22A1 SLC22A4 | 2.94e-06 | 354 | 111 | 11 | GO:0009925 |
| GeneOntologyCellularComponent | transmembrane transporter complex | SCN11A ANO1 SLC9A1 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A CACNA1I CACNA1H CNGA2 | 4.17e-06 | 523 | 111 | 13 | GO:1902495 |
| GeneOntologyCellularComponent | basal part of cell | ABCC5 SLC46A1 SLC2A2 SLC38A1 SLC6A12 SLC7A1 SLC9A1 CADM1 SLC26A7 SLC22A1 SLC22A4 | 5.50e-06 | 378 | 111 | 11 | GO:0045178 |
| GeneOntologyCellularComponent | transporter complex | SCN11A ANO1 SLC9A1 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A CACNA1I CACNA1H CNGA2 | 7.17e-06 | 550 | 111 | 13 | GO:1990351 |
| GeneOntologyCellularComponent | basolateral plasma membrane | ABCC5 SLC46A1 SLC2A2 SLC38A1 SLC6A12 SLC7A1 SLC9A1 CADM1 SLC26A7 SLC22A1 | 8.08e-06 | 320 | 111 | 10 | GO:0016323 |
| GeneOntologyCellularComponent | cell-cell junction | PLXDC1 SLC2A2 ADCYAP1R1 ABCB1 GJA9 SLC9A1 CADM1 SV2A SCN1A SCN2A SCN5A CD53 KIT | 1.54e-05 | 591 | 111 | 13 | GO:0005911 |
| GeneOntologyCellularComponent | presynapse | SCN11A ARL6IP5 ANO1 SLC35G2 SLC1A6 OPRK1 SLC6A1 SLC6A12 CADM1 SV2A SCN1A SLC22A1 SCN2A SCN8A SV2C CACNA1H | 1.78e-05 | 886 | 111 | 16 | GO:0098793 |
| GeneOntologyCellularComponent | T-tubule | 6.36e-05 | 79 | 111 | 5 | GO:0030315 | |
| GeneOntologyCellularComponent | brush border membrane | 8.05e-05 | 83 | 111 | 5 | GO:0031526 | |
| GeneOntologyCellularComponent | membrane protein complex | SCN11A HLA-DQA2 ANO1 PAM16 SLC1A6 DENND4C GJA9 TGFBR3 SLC9A1 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A CACNA1I CACNA1H RNF139 CNGA2 | 1.11e-04 | 1498 | 111 | 20 | GO:0098796 |
| GeneOntologyCellularComponent | node of Ranvier | 1.56e-04 | 20 | 111 | 3 | GO:0033268 | |
| GeneOntologyCellularComponent | plasma membrane protein complex | SCN11A HLA-DQA2 GJA9 TGFBR3 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A CACNA1I CACNA1H | 2.71e-04 | 785 | 111 | 13 | GO:0098797 |
| GeneOntologyCellularComponent | synaptic membrane | SCN11A ANO1 SLC1A6 OPRK1 SLC6A1 CADM1 SCN1A SCN2A SCN8A CACNA1H EPHA7 | 2.75e-04 | 583 | 111 | 11 | GO:0097060 |
| GeneOntologyCellularComponent | external side of apical plasma membrane | 4.13e-04 | 6 | 111 | 2 | GO:0098591 | |
| GeneOntologyCellularComponent | intercalated disc | 4.72e-04 | 68 | 111 | 4 | GO:0014704 | |
| GeneOntologyCellularComponent | axon initial segment | 4.81e-04 | 29 | 111 | 3 | GO:0043194 | |
| GeneOntologyCellularComponent | neuronal cell body | SCN11A PLXDC1 PTGER4 OPRK1 SLC6A1 SLC38A1 SV2A SCN1A SCN3A SCN8A CACNA1H CNGA2 EPHA7 | 4.87e-04 | 835 | 111 | 13 | GO:0043025 |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | HLA-DQA2 ABCC5 SLC46A1 SLC35G2 SLC15A3 SPPL2B SLC30A4 DENND4C OPRK1 SLC26A7 SV2A CD53 DISP3 SV2C CTNS MARCHF1 CNGA2 | 5.22e-04 | 1307 | 111 | 17 | GO:0030659 |
| GeneOntologyCellularComponent | sarcolemma | 5.35e-04 | 190 | 111 | 6 | GO:0042383 | |
| GeneOntologyCellularComponent | vesicle membrane | HLA-DQA2 ABCC5 SLC46A1 SLC35G2 SLC15A3 SPPL2B SLC30A4 DENND4C OPRK1 SLC26A7 SV2A CD53 DISP3 SV2C CTNS MARCHF1 CNGA2 | 6.09e-04 | 1325 | 111 | 17 | GO:0012506 |
| GeneOntologyCellularComponent | anchoring junction | PLXDC1 SLC2A2 ADCYAP1R1 ABCB1 GJA9 SLC9A1 CADM1 SV2A SCN1A SCN2A SCN5A CD53 CD151 KIT | 6.61e-04 | 976 | 111 | 14 | GO:0070161 |
| GeneOntologyCellularComponent | cell surface | HLA-DQA2 ANO1 SLC46A1 ACKR4 ADCYAP1R1 ABCB1 SLC6A1 SLC38A1 TGFBR3 SLC9A1 SCN5A CD53 CD151 ADGRE1 KIT | 7.84e-04 | 1111 | 111 | 15 | GO:0009986 |
| GeneOntologyCellularComponent | axon | SCN11A OPRK1 SLC6A1 SLC38A1 CADM1 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SEMA6A | 8.89e-04 | 891 | 111 | 13 | GO:0030424 |
| GeneOntologyCellularComponent | cell body | SCN11A PLXDC1 PTGER4 OPRK1 SLC6A1 SLC38A1 SV2A SCN1A SCN3A SCN8A CACNA1H CNGA2 EPHA7 | 1.30e-03 | 929 | 111 | 13 | GO:0044297 |
| GeneOntologyCellularComponent | brush border | 1.31e-03 | 152 | 111 | 5 | GO:0005903 | |
| GeneOntologyCellularComponent | cell-cell contact zone | 1.59e-03 | 94 | 111 | 4 | GO:0044291 | |
| GeneOntologyCellularComponent | lumenal side of membrane | 2.12e-03 | 48 | 111 | 3 | GO:0098576 | |
| GeneOntologyCellularComponent | lysosomal membrane | 3.25e-03 | 462 | 111 | 8 | GO:0005765 | |
| GeneOntologyCellularComponent | lytic vacuole membrane | 3.25e-03 | 462 | 111 | 8 | GO:0098852 | |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | PTCHD3 HLA-DQA2 ARL6IP5 DOLK PTDSS2 POMT1 RRBP1 SPPL2B OR8A1 YIPF5 DISP3 OR2A25 RNF139 MARCHF1 MYRF | 3.46e-03 | 1293 | 111 | 15 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | PTCHD3 HLA-DQA2 ARL6IP5 DOLK PTDSS2 POMT1 RRBP1 SPPL2B OR8A1 YIPF5 DISP3 OR2A25 RNF139 MARCHF1 MYRF | 3.61e-03 | 1299 | 111 | 15 | GO:0098827 |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | PTCHD3 HLA-DQA2 ARL6IP5 DOLK PTDSS2 POMT1 RRBP1 SPPL2B OR8A1 YIPF5 DISP3 OR2A25 RNF139 MARCHF1 MYRF | 4.40e-03 | 1327 | 111 | 15 | GO:0042175 |
| GeneOntologyCellularComponent | somatodendritic compartment | SCN11A PLXDC1 PTGER4 OPRK1 SLC6A1 SLC38A1 CADM1 SV2A SCN1A SCN3A SCN8A CACNA1H CNGA2 EPHA7 | 5.50e-03 | 1228 | 111 | 14 | GO:0036477 |
| GeneOntologyCellularComponent | vacuolar membrane | 5.66e-03 | 507 | 111 | 8 | GO:0005774 | |
| GeneOntologyCellularComponent | postsynaptic membrane | 5.90e-03 | 405 | 111 | 7 | GO:0045211 | |
| GeneOntologyCellularComponent | external side of plasma membrane | 6.49e-03 | 519 | 111 | 8 | GO:0009897 | |
| GeneOntologyCellularComponent | cluster of actin-based cell projections | 6.79e-03 | 223 | 111 | 5 | GO:0098862 | |
| HumanPheno | Complex febrile seizure | 6.30e-08 | 16 | 37 | 5 | HP:0011172 | |
| HumanPheno | Photosensitive myoclonic seizure | 1.62e-07 | 8 | 37 | 4 | HP:0001327 | |
| HumanPheno | Cyanotic episode | 1.62e-07 | 8 | 37 | 4 | HP:0200048 | |
| HumanPheno | Focal hemiclonic seizure | 7.31e-07 | 25 | 37 | 5 | HP:0006813 | |
| HumanPheno | Limited neck range of motion | 7.50e-07 | 11 | 37 | 4 | HP:0000466 | |
| HumanPheno | Simple febrile seizure | 1.10e-06 | 27 | 37 | 5 | HP:0011171 | |
| HumanPheno | Epilepsia partialis continua | 1.12e-06 | 12 | 37 | 4 | HP:0012847 | |
| HumanPheno | Pes valgus | 2.40e-06 | 56 | 37 | 6 | HP:0008081 | |
| HumanPheno | Facial tics | 3.04e-06 | 15 | 37 | 4 | HP:0011468 | |
| HumanPheno | Photosensitive tonic-clonic seizure | 3.04e-06 | 15 | 37 | 4 | HP:0007207 | |
| HumanPheno | Generalized clonic seizure | 3.65e-06 | 34 | 37 | 5 | HP:0011169 | |
| HumanPheno | Dysgenesis of the hippocampus | 4.03e-06 | 16 | 37 | 4 | HP:0025101 | |
| HumanPheno | Focal motor status epilepticus | 5.24e-06 | 17 | 37 | 4 | HP:0032663 | |
| HumanPheno | Multifocal epileptiform discharges | 6.37e-06 | 66 | 37 | 6 | HP:0010841 | |
| HumanPheno | Visually-induced seizure | 6.71e-06 | 18 | 37 | 4 | HP:0020216 | |
| HumanPheno | Infection-related seizure | 6.82e-06 | 145 | 37 | 8 | HP:0032892 | |
| HumanPheno | Seizure precipitated by febrile infection | 6.82e-06 | 145 | 37 | 8 | HP:0032894 | |
| HumanPheno | Febrile seizure (within the age range of 3 months to 6 years) | 6.82e-06 | 145 | 37 | 8 | HP:0002373 | |
| HumanPheno | Focal clonic seizure | 1.07e-05 | 42 | 37 | 5 | HP:0002266 | |
| HumanPheno | EEG with generalized epileptiform discharges | DOLK SLC6A1 SV2A SCN1A PCDH19 SCN2A SCN3A SCN8A SCN9A CACNA1H | 1.44e-05 | 270 | 37 | 10 | HP:0011198 |
| HumanPheno | Reflex seizure | 1.57e-05 | 22 | 37 | 4 | HP:0020207 | |
| HumanPheno | Cyanosis | 1.64e-05 | 117 | 37 | 7 | HP:0000961 | |
| HumanPheno | EEG with focal epileptiform discharges | 1.73e-05 | 118 | 37 | 7 | HP:0011185 | |
| HumanPheno | Tibial torsion | 1.89e-05 | 23 | 37 | 4 | HP:0100694 | |
| HumanPheno | Clonic seizure | 2.10e-05 | 81 | 37 | 6 | HP:0020221 | |
| HumanPheno | Bilateral tonic-clonic seizure with generalized onset | 3.10e-05 | 52 | 37 | 5 | HP:0025190 | |
| HumanPheno | EEG with spike-wave complexes | 3.39e-05 | 88 | 37 | 6 | HP:0010850 | |
| HumanPheno | Limited knee extension | 3.67e-05 | 27 | 37 | 4 | HP:0003066 | |
| HumanPheno | Status epilepticus without prominent motor symptoms | 3.67e-05 | 27 | 37 | 4 | HP:0031475 | |
| HumanPheno | Focal aware seizure | 4.26e-05 | 28 | 37 | 4 | HP:0002349 | |
| HumanPheno | Status epilepticus with prominent motor symptoms | 4.92e-05 | 29 | 37 | 4 | HP:0032658 | |
| HumanPheno | Progressive gait ataxia | 5.64e-05 | 30 | 37 | 4 | HP:0007240 | |
| HumanPheno | Progressive ataxia | 5.64e-05 | 30 | 37 | 4 | HP:0001329 | |
| HumanPheno | Interictal epileptiform activity | DOLK SLC6A1 SV2A SCN1A PCDH19 SCN2A SCN3A SCN8A SCN9A CACNA1H | 6.14e-05 | 319 | 37 | 10 | HP:0011182 |
| HumanPheno | Bilateral tonic-clonic seizure | DOLK SLC6A1 YIPF5 SV2A SCN1A PCDH19 SCN2A SCN3A SCN8A SCN9A CACNA1H | 6.99e-05 | 394 | 37 | 11 | HP:0002069 |
| HumanPheno | Interictal EEG abnormality | DOLK SLC6A1 SV2A SCN1A PCDH19 SCN2A SCN3A SCN8A SCN9A CACNA1H | 7.19e-05 | 325 | 37 | 10 | HP:0025373 |
| HumanPheno | Cogwheel rigidity | 7.33e-05 | 32 | 37 | 4 | HP:0002396 | |
| HumanPheno | Focal automatism seizure | 7.42e-05 | 12 | 37 | 3 | HP:0032898 | |
| HumanPheno | Obsessive-compulsive trait | 8.30e-05 | 33 | 37 | 4 | HP:0008770 | |
| HumanPheno | Generalized tonic seizure | 8.54e-05 | 64 | 37 | 5 | HP:0010818 | |
| HumanPheno | Generalized cerebral atrophy/hypoplasia | 9.60e-05 | 13 | 37 | 3 | HP:0007058 | |
| HumanPheno | Limitation of knee mobility | 1.05e-04 | 35 | 37 | 4 | HP:0010501 | |
| HumanPheno | Limitation of neck motion | 1.18e-04 | 36 | 37 | 4 | HP:0005986 | |
| HumanPheno | Abnormal neck physiology | 1.18e-04 | 36 | 37 | 4 | HP:0025669 | |
| HumanPheno | Disturbance of facial expression | 1.18e-04 | 36 | 37 | 4 | HP:0005324 | |
| HumanPheno | Focal non-motor seizure | 1.79e-04 | 40 | 37 | 4 | HP:0032679 | |
| HumanPheno | Generalized non-motor (absence) seizure | 2.23e-04 | 176 | 37 | 7 | HP:0002121 | |
| HumanPheno | Atypical absence status epilepticus | 2.24e-04 | 17 | 37 | 3 | HP:0011151 | |
| HumanPheno | Focal impaired awareness seizure | 2.52e-04 | 126 | 37 | 6 | HP:0002384 | |
| HumanPheno | Generalized non-convulsive status epilepticus without coma | 2.67e-04 | 18 | 37 | 3 | HP:0032860 | |
| HumanPheno | Atypical absence seizure | 3.09e-04 | 46 | 37 | 4 | HP:0007270 | |
| HumanPheno | Poor motor coordination | 3.29e-04 | 85 | 37 | 5 | HP:0002275 | |
| HumanPheno | Dialeptic seizure | 3.45e-04 | 251 | 37 | 8 | HP:0011146 | |
| HumanPheno | Abnormal hippocampus morphology | 3.65e-04 | 48 | 37 | 4 | HP:0025100 | |
| HumanPheno | Non-convulsive status epilepticus without coma | 3.69e-04 | 20 | 37 | 3 | HP:0032671 | |
| HumanPheno | EEG with abnormally slow frequencies | 3.87e-04 | 88 | 37 | 5 | HP:0011203 | |
| HumanPheno | Abnormal morphology of the limbic system | 3.95e-04 | 49 | 37 | 4 | HP:0007343 | |
| HumanPheno | Talipes valgus | 4.29e-04 | 21 | 37 | 3 | HP:0004684 | |
| HumanPheno | Tonic seizure | 4.46e-04 | 140 | 37 | 6 | HP:0032792 | |
| HumanPheno | Non-motor seizure | 4.46e-04 | 197 | 37 | 7 | HP:0033259 | |
| HumanPheno | Second trimester onset | 4.61e-04 | 51 | 37 | 4 | HP:0034198 | |
| HumanPheno | Focal sensory seizure | 4.94e-04 | 22 | 37 | 3 | HP:0011157 | |
| HumanPheno | Neonatal electro-clinical non-motor seizure | 5.06e-04 | 5 | 37 | 2 | HP:0032812 | |
| HumanPheno | Neonatal seizure with electrographic correlate | 5.06e-04 | 5 | 37 | 2 | HP:0032808 | |
| HumanPheno | Neonatal electro-clinical seizure | 5.06e-04 | 5 | 37 | 2 | HP:0032809 | |
| HumanPheno | Neonatal electro-clinical seizure with behavior arrest | 5.06e-04 | 5 | 37 | 2 | HP:0032823 | |
| HumanPheno | Focal head nodding automatism seizure | 5.06e-04 | 5 | 37 | 2 | HP:0032906 | |
| HumanPheno | Allodynia | 5.06e-04 | 5 | 37 | 2 | HP:0012533 | |
| HumanPheno | Atonic seizure | 5.25e-04 | 94 | 37 | 5 | HP:0010819 | |
| HumanPheno | Generalized myoclonic seizure | 6.00e-04 | 148 | 37 | 6 | HP:0002123 | |
| HumanPheno | Impulsivity | 6.22e-04 | 149 | 37 | 6 | HP:0100710 | |
| HumanPheno | Action tremor | 6.56e-04 | 210 | 37 | 7 | HP:0002345 | |
| HumanPheno | Cortical dysplasia | 6.61e-04 | 56 | 37 | 4 | HP:0002539 | |
| HumanPheno | Epileptic aura | 7.27e-04 | 25 | 37 | 3 | HP:0033348 | |
| HumanPheno | Rigidity | 7.34e-04 | 214 | 37 | 7 | HP:0002063 | |
| HumanPheno | Normal interictal EEG | 7.56e-04 | 6 | 37 | 2 | HP:0002372 | |
| HumanPheno | Intellectual disability, profound | 1.03e-03 | 109 | 37 | 5 | HP:0002187 | |
| HumanPheno | Eyelid myoclonia seizure | 1.05e-03 | 7 | 37 | 2 | HP:0032678 | |
| HumanPheno | EEG with generalized slow activity | 1.13e-03 | 29 | 37 | 3 | HP:0010845 | |
| HumanPheno | Limb myoclonus | 1.13e-03 | 29 | 37 | 3 | HP:0045084 | |
| HumanPheno | Generalized-onset seizure | DOLK SLC6A1 YIPF5 SV2A SCN1A PCDH19 SCN2A SCN3A SCN8A SCN9A CACNA1H | 1.19e-03 | 544 | 37 | 11 | HP:0002197 |
| HumanPheno | EEG abnormality | DOLK POMT1 SLC6A1 SV2A SCN1A PCDH19 SCN2A SCN3A SCN8A SCN9A CACNA1H | 1.26e-03 | 548 | 37 | 11 | HP:0002353 |
| HumanPheno | Tremor | RNASEH2A FLVCR1 SLC6A1 SLC9A1 PROKR2 SCN1A PCDH19 SCN2A TMEM70 SCN3A SCN8A SCN9A | 1.28e-03 | 639 | 37 | 12 | HP:0001337 |
| HumanPheno | Childhood onset | FLVCR1 HECTD4 ANO1 POMT1 SLC6A1 SLC9A1 SCN1A PCDH19 SCN2A SCN3A SCN5A SCN8A CACNA1I CACNA1H MYRF | 1.38e-03 | 938 | 37 | 15 | HP:0011463 |
| HumanPheno | Hemiplegia/hemiparesis | 1.44e-03 | 240 | 37 | 7 | HP:0004374 | |
| HumanPheno | Poor fine motor coordination | 1.45e-03 | 69 | 37 | 4 | HP:0007010 | |
| HumanPheno | Epileptic encephalopathy | 1.53e-03 | 119 | 37 | 5 | HP:0200134 | |
| MousePheno | abnormal action potential | 9.76e-07 | 133 | 81 | 8 | MP:0005402 | |
| MousePheno | abnormal nervous system electrophysiology | SCN11A SLC1A6 SCN1A PCDH19 SCN2A SCN5A SCN8A SCN9A CACNA1I KIT | 1.94e-05 | 329 | 81 | 10 | MP:0002272 |
| Domain | Na_channel_asu | 3.13e-17 | 10 | 104 | 8 | IPR001696 | |
| Domain | Na_trans_assoc | 3.13e-17 | 10 | 104 | 8 | IPR010526 | |
| Domain | Na_trans_assoc | 3.13e-17 | 10 | 104 | 8 | PF06512 | |
| Domain | Na_trans_cytopl | 2.58e-14 | 6 | 104 | 6 | PF11933 | |
| Domain | Na_trans_cytopl | 2.58e-14 | 6 | 104 | 6 | IPR024583 | |
| Domain | Channel_four-helix_dom | SCN11A SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A CACNA1I CACNA1H | 6.40e-13 | 57 | 104 | 10 | IPR027359 |
| Domain | - | SCN11A SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A CACNA1I CACNA1H | 6.40e-13 | 57 | 104 | 10 | 1.20.120.350 |
| Domain | Ion_trans_dom | SCN11A SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A CACNA1I CACNA1H CNGA2 | 3.72e-11 | 114 | 104 | 11 | IPR005821 |
| Domain | Ion_trans | SCN11A SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A CACNA1I CACNA1H CNGA2 | 3.72e-11 | 114 | 104 | 11 | PF00520 |
| Domain | Sugar_transporter_CS | 4.06e-10 | 32 | 104 | 7 | IPR005829 | |
| Domain | MFS_dom | SLC2A7 FLVCR1 MFSD4A SLC46A1 SLC15A3 SLC2A2 SV2A SLC22A1 SLC22A4 SV2C | 3.79e-09 | 134 | 104 | 10 | IPR020846 |
| Domain | MFS | SLC2A7 FLVCR1 MFSD4A SLC46A1 SLC2A2 SV2A SLC22A1 SLC22A4 SV2C | 8.97e-09 | 108 | 104 | 9 | PS50850 |
| Domain | 7tm_1 | GPR3 OR8D2 OR10J3 OR1C1 OR14C36 ACKR4 OR2T4 PTGER4 OPRK1 OR10G7 OR8A1 OR4C15 PROKR2 OR4A5 OR4A16 OR2A25 OR8D4 OR4C5 | 3.36e-08 | 677 | 104 | 18 | PF00001 |
| Domain | G_PROTEIN_RECEP_F1_1 | GPR3 OR8D2 OR10J3 OR1C1 OR14C36 ACKR4 OR2T4 PTGER4 OPRK1 OR10G7 OR8A1 OR4C15 PROKR2 OR4A5 OR4A16 OR2A25 OR8D4 OR4C5 | 4.01e-08 | 685 | 104 | 18 | PS00237 |
| Domain | MFS_sugar_transport-like | 4.38e-08 | 36 | 104 | 6 | IPR005828 | |
| Domain | Sugar_tr | 4.38e-08 | 36 | 104 | 6 | PF00083 | |
| Domain | G_PROTEIN_RECEP_F1_2 | GPR3 OR8D2 OR10J3 OR1C1 OR14C36 ACKR4 OR2T4 PTGER4 OPRK1 OR10G7 OR8A1 OR4C15 PROKR2 OR4A5 OR4A16 OR2A25 OR8D4 OR4C5 | 4.58e-08 | 691 | 104 | 18 | PS50262 |
| Domain | GPCR_Rhodpsn | GPR3 OR8D2 OR10J3 OR1C1 OR14C36 ACKR4 OR2T4 PTGER4 OPRK1 OR10G7 OR8A1 OR4C15 PROKR2 OR4A5 OR4A16 OR2A25 OR8D4 OR4C5 | 4.68e-08 | 692 | 104 | 18 | IPR000276 |
| Domain | AA-permease/SLC12A_dom | 1.19e-07 | 22 | 104 | 5 | IPR004841 | |
| Domain | AA_permease | 1.19e-07 | 22 | 104 | 5 | PF00324 | |
| Domain | GPCR_Rhodpsn_7TM | GPR3 OR8D2 OR10J3 OR1C1 OR14C36 ACKR4 OR2T4 PTGER4 OPRK1 OR10G7 OR8A1 OR4C15 PROKR2 OR4A5 OR4A16 OR2A25 OR8D4 | 1.65e-07 | 670 | 104 | 17 | IPR017452 |
| Domain | Olfact_rcpt | OR8D2 OR10J3 OR1C1 OR14C36 OR2T4 OR10G7 OR8A1 OR4C15 OR4A5 OR4A16 OR2A25 OR8D4 OR4C5 | 2.82e-07 | 393 | 104 | 13 | IPR000725 |
| Domain | IQ | 3.36e-07 | 81 | 104 | 7 | SM00015 | |
| Domain | IQ_motif_EF-hand-BS | 6.92e-07 | 90 | 104 | 7 | IPR000048 | |
| Domain | IQ | 8.66e-07 | 93 | 104 | 7 | PS50096 | |
| Domain | MFS_1 | 4.44e-06 | 77 | 104 | 6 | PF07690 | |
| Domain | MFS | 4.44e-06 | 77 | 104 | 6 | IPR011701 | |
| Domain | SUGAR_TRANSPORT_1 | 8.85e-06 | 24 | 104 | 4 | PS00216 | |
| Domain | AA_permease_2 | 4.61e-05 | 13 | 104 | 3 | PF13520 | |
| Domain | AA/rel_permease1 | 4.61e-05 | 13 | 104 | 3 | IPR002293 | |
| Domain | IQ | 4.73e-05 | 71 | 104 | 5 | PF00612 | |
| Domain | SV2 | 9.18e-05 | 3 | 104 | 2 | IPR022308 | |
| Domain | Pentapeptide_4 | 9.18e-05 | 3 | 104 | 2 | PF13599 | |
| Domain | VDCC_T_a1 | 9.18e-05 | 3 | 104 | 2 | IPR005445 | |
| Domain | Cat_AA_permease | 9.18e-05 | 3 | 104 | 2 | IPR004755 | |
| Domain | NA_NEUROTRAN_SYMP_2 | 1.29e-04 | 18 | 104 | 3 | PS00754 | |
| Domain | SNF | 1.52e-04 | 19 | 104 | 3 | PF00209 | |
| Domain | NA_NEUROTRAN_SYMP_1 | 1.52e-04 | 19 | 104 | 3 | PS00610 | |
| Domain | NA_NEUROTRAN_SYMP_3 | 1.52e-04 | 19 | 104 | 3 | PS50267 | |
| Domain | Na/ntran_symport | 1.52e-04 | 19 | 104 | 3 | IPR000175 | |
| Domain | 5peptide_repeat | 1.83e-04 | 4 | 104 | 2 | IPR001646 | |
| Domain | Tetraspanin_CS | 2.07e-04 | 21 | 104 | 3 | IPR018503 | |
| Domain | CAT3 | 3.04e-04 | 5 | 104 | 2 | IPR015606 | |
| Domain | AA_permease_C | 3.04e-04 | 5 | 104 | 2 | PF13906 | |
| Domain | CAT_C | 3.04e-04 | 5 | 104 | 2 | IPR029485 | |
| Domain | TM4_1 | 3.97e-04 | 26 | 104 | 3 | PS00421 | |
| Domain | Tetraspanin | 7.40e-04 | 32 | 104 | 3 | IPR000301 | |
| Domain | Tetraspanin_EC2 | 7.40e-04 | 32 | 104 | 3 | IPR008952 | |
| Domain | Tetraspannin | 8.10e-04 | 33 | 104 | 3 | PF00335 | |
| Domain | Tetraspanin/Peripherin | 8.10e-04 | 33 | 104 | 3 | IPR018499 | |
| Domain | Ptc/Disp | 1.08e-03 | 9 | 104 | 2 | IPR003392 | |
| Domain | Patched | 1.08e-03 | 9 | 104 | 2 | PF02460 | |
| Domain | Orgcat_transp/SVOP | 1.08e-03 | 9 | 104 | 2 | IPR004749 | |
| Domain | Anoctamin | 1.34e-03 | 10 | 104 | 2 | PF04547 | |
| Domain | Anoctamin | 1.34e-03 | 10 | 104 | 2 | IPR007632 | |
| Domain | VDCCAlpha1 | 1.34e-03 | 10 | 104 | 2 | IPR002077 | |
| Domain | NA_SOLUT_SYMP_1 | 1.63e-03 | 11 | 104 | 2 | PS00456 | |
| Domain | NA_SOLUT_SYMP_2 | 1.95e-03 | 12 | 104 | 2 | PS00457 | |
| Domain | SSF | 1.95e-03 | 12 | 104 | 2 | PF00474 | |
| Domain | Na/solute_symporter | 1.95e-03 | 12 | 104 | 2 | IPR001734 | |
| Domain | NA_SOLUT_SYMP_3 | 1.95e-03 | 12 | 104 | 2 | PS50283 | |
| Domain | SSD | 2.30e-03 | 13 | 104 | 2 | IPR000731 | |
| Domain | SSD | 2.30e-03 | 13 | 104 | 2 | PS50156 | |
| Domain | ABC_tran | 2.42e-03 | 48 | 104 | 3 | PF00005 | |
| Domain | ABC_TRANSPORTER_2 | 2.42e-03 | 48 | 104 | 3 | PS50893 | |
| Domain | ABC_TRANSPORTER_1 | 2.57e-03 | 49 | 104 | 3 | PS00211 | |
| Domain | Sugar/inositol_transpt | 2.68e-03 | 14 | 104 | 2 | IPR003663 | |
| Domain | ABC_transporter-like | 2.72e-03 | 50 | 104 | 3 | IPR003439 | |
| Domain | Znf_RING-CH | 3.95e-03 | 17 | 104 | 2 | IPR011016 | |
| Domain | SUGAR_TRANSPORT_2 | 3.95e-03 | 17 | 104 | 2 | PS00217 | |
| Domain | RINGv | 3.95e-03 | 17 | 104 | 2 | SM00744 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLC2A7 SLC15A3 SLC7A6 SLC1A6 SLC2A2 SLC6A1 SLC38A1 SLC6A12 SLC7A1 SLC7A2 SLC9A1 SLC26A7 SLC22A1 SLC22A4 SLC6A20 CTNS SLC5A12 SLC5A8 | 2.78e-14 | 249 | 92 | 18 | M5988 |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLC2A7 SLC15A3 SLC7A6 SLC1A6 SLC2A2 SLC6A1 SLC38A1 SLC6A12 SLC7A1 SLC9A1 SLC26A7 SLC22A1 SLC22A4 SLC6A20 CTNS SLC5A12 SLC5A8 | 1.90e-13 | 238 | 92 | 17 | MM15076 |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | SLC15A3 SLC7A6 SLC1A6 SLC38A1 SLC6A12 SLC7A1 SLC7A2 SLC9A1 SLC26A7 SLC6A20 CTNS SLC5A12 SLC5A8 | 2.02e-13 | 108 | 92 | 13 | M823 |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | ANO9 CYBRD1 SLC2A7 FLVCR1 ANO1 ABCC5 SLC46A1 SLC15A3 SLC7A6 ABCA9 SLC1A6 SLC2A2 ABCB1 SLC6A1 SLC38A1 SLC6A12 SLC7A1 SLC7A2 SLC9A1 SLC26A7 SLC22A1 SLC22A4 SLC6A20 CTNS SLC5A12 SLC5A8 | 6.36e-13 | 736 | 92 | 26 | M27287 |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | ANO9 CYBRD1 SLC2A7 FLVCR1 ANO1 ABCC5 SLC46A1 SLC15A3 SLC7A6 ABCA9 SLC1A6 SLC2A2 ABCB1 SLC6A1 SLC38A1 SLC6A12 SLC7A1 SLC9A1 SLC26A7 SLC22A1 SLC22A4 SLC6A20 CTNS SLC5A12 SLC5A8 | 8.40e-13 | 681 | 92 | 25 | MM14985 |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | SLC15A3 SLC7A6 SLC1A6 SLC38A1 SLC6A12 SLC7A1 SLC9A1 SLC26A7 SLC6A20 CTNS SLC5A12 SLC5A8 | 5.33e-12 | 109 | 92 | 12 | MM15074 |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 1.68e-11 | 31 | 92 | 8 | M877 | |
| Pathway | REACTOME_PHASE_0_RAPID_DEPOLARISATION | 2.23e-11 | 32 | 92 | 8 | M27455 | |
| Pathway | REACTOME_AMINO_ACID_TRANSPORT_ACROSS_THE_PLASMA_MEMBRANE | 6.30e-08 | 33 | 92 | 6 | M188 | |
| Pathway | REACTOME_OLFACTORY_SIGNALING_PATHWAY | OR8D2 OR10J3 OR1C1 OR14C36 OR2T4 OR10G7 OR8A1 OR4C15 OR4A8 OR4A5 OR4A16 OR2A25 OR8D4 CNGA2 OR4C5 | 7.39e-08 | 417 | 92 | 15 | M4072 |
| Pathway | REACTOME_SENSORY_PERCEPTION | OR8D2 OR10J3 OR1C1 OR14C36 OR2T4 OR10G7 OR8A1 OR4C15 OR4A8 OR4A5 OR4A16 SCN2A SCN3A SCN9A OR2A25 OR8D4 CNGA2 OR4C5 | 1.21e-07 | 636 | 92 | 18 | M41834 |
| Pathway | REACTOME_MUSCLE_CONTRACTION | SCN11A SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A CACNA1I CACNA1H | 7.94e-07 | 203 | 92 | 10 | M5485 |
| Pathway | WP_DRAVET_SYNDROME | 9.26e-07 | 28 | 92 | 5 | M45519 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 1.19e-06 | 121 | 92 | 8 | M872 | |
| Pathway | REACTOME_AMINO_ACID_TRANSPORT_ACROSS_THE_PLASMA_MEMBRANE | 1.86e-06 | 32 | 92 | 5 | MM14957 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 2.05e-06 | 130 | 92 | 8 | M27454 | |
| Pathway | REACTOME_NA_CL_DEPENDENT_NEUROTRANSMITTER_TRANSPORTERS | 6.11e-06 | 19 | 92 | 4 | M27362 | |
| Pathway | REACTOME_NA_CL_DEPENDENT_NEUROTRANSMITTER_TRANSPORTERS | 6.11e-06 | 19 | 92 | 4 | MM15107 | |
| Pathway | KEGG_OLFACTORY_TRANSDUCTION | OR8D2 OR10J3 OR1C1 OR14C36 OR2T4 OR10G7 OR8A1 OR4C15 OR4A5 OR4A16 OR2A25 OR8D4 | 8.16e-06 | 389 | 92 | 12 | M14091 |
| Pathway | REACTOME_NEUROTRANSMITTER_RELEASE_CYCLE | 1.97e-05 | 51 | 92 | 5 | M4281 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RELEASE_CYCLE | 1.97e-05 | 51 | 92 | 5 | MM14499 | |
| Pathway | WP_ADHD_AND_AUTISM_ASD_PATHWAYS | SCN11A SLC46A1 SLC6A1 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A KIT | 2.61e-05 | 367 | 92 | 11 | M48346 |
| Pathway | WP_NRF2_PATHWAY | 3.72e-05 | 141 | 92 | 7 | M39454 | |
| Pathway | REACTOME_TRANSPORT_OF_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS | 1.36e-04 | 76 | 92 | 5 | MM15072 | |
| Pathway | WP_NUCLEAR_RECEPTORS_METAPATHWAY | SLC2A7 ABCC5 SLC2A2 ABCB1 SLC6A1 TGFBR3 SLC6A20 SLC5A12 SLC5A8 | 2.07e-04 | 314 | 92 | 9 | M39428 |
| Pathway | REACTOME_TRANSPORT_OF_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS | 2.18e-04 | 84 | 92 | 5 | M27334 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | SCN11A SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A CACNA1I CACNA1H SEMA6A EPHA7 | 3.48e-04 | 575 | 92 | 12 | M29853 |
| Pathway | REACTOME_TOXICITY_OF_BOTULINUM_TOXIN_TYPE_D_BOTD | 4.16e-04 | 5 | 92 | 2 | M27427 | |
| Pathway | REACTOME_ABACAVIR_TRANSMEMBRANE_TRANSPORT | 4.16e-04 | 5 | 92 | 2 | M27147 | |
| Pathway | WP_PROXIMAL_TUBULE_TRANSPORT | 5.15e-04 | 57 | 92 | 4 | M39812 | |
| Pathway | REACTOME_ORGANIC_CATION_TRANSPORT | 1.15e-03 | 8 | 92 | 2 | MM15191 | |
| Pathway | WP_DRAVET_SYNDROME_SCN1AA1783V_POINT_MUTATION_MODEL | 1.31e-03 | 73 | 92 | 4 | MM16641 | |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | 1.36e-03 | 186 | 92 | 6 | MM15994 | |
| Pathway | REACTOME_ABACAVIR_ADME | 1.47e-03 | 9 | 92 | 2 | M677 | |
| Pathway | REACTOME_MULTIFUNCTIONAL_ANION_EXCHANGERS | 1.47e-03 | 9 | 92 | 2 | M27344 | |
| Pathway | REACTOME_MULTIFUNCTIONAL_ANION_EXCHANGERS | 1.47e-03 | 9 | 92 | 2 | MM15084 | |
| Pathway | REACTOME_ORGANIC_CATION_TRANSPORT | 1.83e-03 | 10 | 92 | 2 | M27450 | |
| Pathway | REACTOME_NEUROTOXICITY_OF_CLOSTRIDIUM_TOXINS | 1.83e-03 | 10 | 92 | 2 | M27018 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | 2.57e-03 | 211 | 92 | 6 | MM14502 | |
| Pathway | REACTOME_ORGANIC_CATION_ANION_ZWITTERION_TRANSPORT | 2.66e-03 | 12 | 92 | 2 | MM15192 | |
| Pathway | KEGG_ABC_TRANSPORTERS | 2.94e-03 | 44 | 92 | 3 | M11911 | |
| Pathway | REACTOME_INDUCTION_OF_CELL_CELL_FUSION | 3.14e-03 | 13 | 92 | 2 | M46426 | |
| Pathway | REACTOME_SENSORY_PERCEPTION_OF_TASTE | 3.54e-03 | 47 | 92 | 3 | M42524 | |
| Pathway | WP_RETT_SYNDROME | 3.76e-03 | 48 | 92 | 3 | M39759 | |
| Pubmed | 7.47e-20 | 9 | 111 | 8 | 16382098 | ||
| Pubmed | 7.68e-14 | 9 | 111 | 6 | 15746173 | ||
| Pubmed | Early development of electrical excitability in the mouse enteric nervous system. | 3.02e-13 | 5 | 111 | 5 | 22875929 | |
| Pubmed | 3.02e-13 | 5 | 111 | 5 | 17724025 | ||
| Pubmed | 1.55e-12 | 13 | 111 | 6 | 15123669 | ||
| Pubmed | A 'toothache tree' alkylamide inhibits Aδ mechanonociceptors to alleviate mechanical pain. | 1.81e-12 | 6 | 111 | 5 | 23652591 | |
| Pubmed | Odorant and vomeronasal receptor genes in two mouse genome assemblies. | 2.29e-12 | 74 | 111 | 9 | 15081110 | |
| Pubmed | Different evolutionary processes shaped the mouse and human olfactory receptor gene families. | OR8D2 OR10J3 OR14C36 OR2T4 OR10G7 OR8A1 OR4C15 OR4A8 OR4A5 OR4A16 OR2A25 OR13C7 OR8D4 OR4C5 | 4.99e-12 | 340 | 111 | 14 | 11875048 |
| Pubmed | OR8D2 OR10J3 OR14C36 OR2T4 OR10G7 OR8A1 OR4C15 OR4A8 OR4A5 OR4A16 OR2A25 OR13C7 OR8D4 OR4C5 | 4.99e-12 | 340 | 111 | 14 | 11802173 | |
| Pubmed | OR8D2 OR10J3 OR14C36 OR2T4 OR10G7 OR8A1 OR4C15 OR4A8 OR4A5 OR4A16 OR2A25 OR13C7 OR8D4 OR4C5 | 5.61e-12 | 343 | 111 | 14 | 32295537 | |
| Pubmed | OR8D2 OR10J3 OR14C36 OR2T4 OR10G7 OR8A1 OR4C15 OR4A8 OR4A5 OR4A16 OR2A25 OR13C7 OR8D4 OR4C5 | 6.31e-12 | 346 | 111 | 14 | 14611657 | |
| Pubmed | 9.83e-11 | 4 | 111 | 4 | 17537961 | ||
| Pubmed | 9.83e-11 | 4 | 111 | 4 | 35031483 | ||
| Pubmed | 9.83e-11 | 4 | 111 | 4 | 29578003 | ||
| Pubmed | Nav1.2 haplodeficiency in excitatory neurons causes absence-like seizures in mice. | 2.35e-10 | 12 | 111 | 5 | 30175250 | |
| Pubmed | 4.90e-10 | 5 | 111 | 4 | 8812438 | ||
| Pubmed | Amino acid transport across mammalian intestinal and renal epithelia. | 6.36e-10 | 31 | 111 | 6 | 18195088 | |
| Pubmed | Are voltage-dependent ion channels involved in the endothelial cell control of vasomotor tone? | 1.47e-09 | 6 | 111 | 4 | 17513486 | |
| Pubmed | 1.80e-09 | 105 | 111 | 8 | 30280653 | ||
| Pubmed | Diagnostic yield of genetic testing in epileptic encephalopathy in childhood. | 3.41e-09 | 7 | 111 | 4 | 25818041 | |
| Pubmed | Large-scale analysis of ion channel gene expression in the mouse heart during perinatal development. | 1.66e-08 | 139 | 111 | 8 | 16985003 | |
| Pubmed | OR8D2 OR10J3 OR1C1 OR14C36 OR2T4 OR10G7 OR8A1 OR4C15 OR4A8 OR4A5 OR4A16 OR8D4 OR4C5 | 2.03e-08 | 541 | 111 | 13 | 14983052 | |
| Pubmed | 3.16e-08 | 3 | 111 | 3 | 19284629 | ||
| Pubmed | 3.16e-08 | 3 | 111 | 3 | 33895391 | ||
| Pubmed | 3.16e-08 | 3 | 111 | 3 | 23859570 | ||
| Pubmed | 3.16e-08 | 3 | 111 | 3 | 12610651 | ||
| Pubmed | 3.16e-08 | 3 | 111 | 3 | 18784617 | ||
| Pubmed | 3.16e-08 | 3 | 111 | 3 | 17544618 | ||
| Pubmed | 3.16e-08 | 3 | 111 | 3 | 32845893 | ||
| Pubmed | 3.16e-08 | 3 | 111 | 3 | 20038812 | ||
| Pubmed | 3.16e-08 | 3 | 111 | 3 | 28518218 | ||
| Pubmed | 3.16e-08 | 3 | 111 | 3 | 17928448 | ||
| Pubmed | 3.16e-08 | 3 | 111 | 3 | 14973256 | ||
| Pubmed | 3.16e-08 | 3 | 111 | 3 | 15302875 | ||
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | FLVCR1 ABCC5 PAM16 ABCB1 SLC38A1 SLC7A1 SLC7A2 SLC9A1 CADM1 SLC22A4 SEMA6A MYRF EPHA7 | 3.65e-08 | 569 | 111 | 13 | 30639242 |
| Pubmed | Pharmacogenetics of antiepileptic drug efficacy in childhood absence epilepsy. | 1.26e-07 | 4 | 111 | 3 | 28165634 | |
| Pubmed | 1.26e-07 | 4 | 111 | 3 | 35801810 | ||
| Pubmed | 1.26e-07 | 4 | 111 | 3 | 21156207 | ||
| Pubmed | Use of recombinant inbred strains for studying genetic determinants of responses to alcohol. | 1.26e-07 | 4 | 111 | 3 | 8974318 | |
| Pubmed | 2.90e-07 | 18 | 111 | 4 | 31791063 | ||
| Pubmed | 3.15e-07 | 5 | 111 | 3 | 1679748 | ||
| Pubmed | 3.15e-07 | 5 | 111 | 3 | 24337656 | ||
| Pubmed | Ca2+-activated Cl− currents are dispensable for olfaction. | 3.15e-07 | 5 | 111 | 3 | 21516098 | |
| Pubmed | 4.07e-07 | 143 | 111 | 7 | 20424473 | ||
| Pubmed | 6.28e-07 | 6 | 111 | 3 | 16029194 | ||
| Pubmed | 6.28e-07 | 6 | 111 | 3 | 23711479 | ||
| Pubmed | 6.97e-07 | 52 | 111 | 5 | 26590417 | ||
| Pubmed | 1.10e-06 | 7 | 111 | 3 | 15272007 | ||
| Pubmed | Pain without nociceptors? Nav1.7-independent pain mechanisms. | 1.10e-06 | 7 | 111 | 3 | 24440715 | |
| Pubmed | 1.75e-06 | 8 | 111 | 3 | 25101983 | ||
| Pubmed | 1.75e-06 | 8 | 111 | 3 | 9412493 | ||
| Pubmed | Sodium channel Scn1b null mice exhibit prolonged QT and RR intervals. | 2.62e-06 | 9 | 111 | 3 | 17884088 | |
| Pubmed | 3.74e-06 | 10 | 111 | 3 | 20602612 | ||
| Pubmed | 6.40e-06 | 405 | 111 | 9 | 38187761 | ||
| Pubmed | 6.67e-06 | 38 | 111 | 4 | 22908908 | ||
| Pubmed | 6.82e-06 | 12 | 111 | 3 | 8169823 | ||
| Pubmed | Pancreatic islet and progenitor cell surface markers with cell sorting potential. | 8.57e-06 | 86 | 111 | 5 | 21947380 | |
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 20346423 | ||
| Pubmed | Reduction of Kcnt1 is therapeutic in mouse models of SCN1A and SCN8A epilepsy. | 1.01e-05 | 2 | 111 | 2 | 37901435 | |
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 18079277 | ||
| Pubmed | A T-type calcium channel required for normal function of a mammalian mechanoreceptor. | 1.01e-05 | 2 | 111 | 2 | 12808460 | |
| Pubmed | An Scn1a epilepsy mutation in Scn8a alters seizure susceptibility and behavior. | 1.01e-05 | 2 | 111 | 2 | 26410685 | |
| Pubmed | Neuronal death and perinatal lethality in voltage-gated sodium channel alpha(II)-deficient mice. | 1.01e-05 | 2 | 111 | 2 | 10827969 | |
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 25071191 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 19694741 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 35348308 | ||
| Pubmed | Genomic structures of SCN2A and SCN3A - candidate genes for deafness at the DFNA16 locus. | 1.01e-05 | 2 | 111 | 2 | 11245985 | |
| Pubmed | Activity-dependent plasticity in the olfactory intrabulbar map. | 1.01e-05 | 2 | 111 | 2 | 17079653 | |
| Pubmed | DOG1 and CD117 are the antibodies of choice in the diagnosis of gastrointestinal stromal tumours. | 1.01e-05 | 2 | 111 | 2 | 20716168 | |
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 15760941 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 33452672 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 31732694 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 36786913 | ||
| Pubmed | [Expression of MDR1 and KIT in imatinib-resistant gastrointestinal stromal tumor cells]. | 1.01e-05 | 2 | 111 | 2 | 20658364 | |
| Pubmed | Differential expression of two sodium channel subtypes in human brain. | 1.01e-05 | 2 | 111 | 2 | 1317301 | |
| Pubmed | Duplication of the sodium channel gene cluster on 2q24 in children with early onset epilepsy. | 1.01e-05 | 2 | 111 | 2 | 23016767 | |
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 17609683 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 27153334 | ||
| Pubmed | Electrophysiological Differences between the Same Pore Region Mutation in SCN1A and SCN3A. | 1.01e-05 | 2 | 111 | 2 | 24990319 | |
| Pubmed | Na+ current properties in islet α- and β-cells reflect cell-specific Scn3a and Scn9a expression. | 1.01e-05 | 2 | 111 | 2 | 25172946 | |
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 31439038 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 23786015 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 28684763 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 30274012 | ||
| Pubmed | The importance of cationic amino acid transporter expression in human skin. | 1.01e-05 | 2 | 111 | 2 | 12787129 | |
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 21504426 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 31943325 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 11834499 | ||
| Pubmed | Severe epilepsy, retardation, and dysmorphic features with a 2q deletion including SCN1A and SCN2A. | 1.01e-05 | 2 | 111 | 2 | 15249644 | |
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 17803828 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 27690330 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 27979828 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 9174363 | ||
| Pubmed | Sodium channel slow inactivation interferes with open channel block. | 1.01e-05 | 2 | 111 | 2 | 27174182 | |
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 18601978 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 33937968 | ||
| Pubmed | Correlations in timing of sodium channel expression, epilepsy, and sudden death in Dravet syndrome. | 1.01e-05 | 2 | 111 | 2 | 23965409 | |
| Pubmed | FGF14 N-terminal splice variants differentially modulate Nav1.2 and Nav1.6-encoded sodium channels. | 1.01e-05 | 2 | 111 | 2 | 19465131 | |
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 8195186 | ||
| Pubmed | Isoform-specific effects of the beta2 subunit on voltage-gated sodium channel gating. | 1.01e-05 | 2 | 111 | 2 | 16847056 | |
| Interaction | SCN11A interactions | 9.12e-09 | 15 | 103 | 5 | int:SCN11A | |
| Interaction | TSPAN15 interactions | TM9SF1 ARL6IP5 PAM16 PTDSS2 SLC7A6 SLC7A1 SLC7A2 YIPF5 SLC22A4 TMEM70 SCN4A | 1.71e-07 | 276 | 103 | 11 | int:TSPAN15 |
| Interaction | NALCN interactions | 6.19e-07 | 14 | 103 | 4 | int:NALCN | |
| Interaction | GPR89A interactions | 2.75e-06 | 120 | 103 | 7 | int:GPR89A | |
| Interaction | SCN8A interactions | 2.93e-06 | 20 | 103 | 4 | int:SCN8A | |
| Interaction | SCN9A interactions | 3.60e-06 | 21 | 103 | 4 | int:SCN9A | |
| Interaction | SCN5A interactions | 4.09e-06 | 47 | 103 | 5 | int:SCN5A | |
| Interaction | CACNA1D interactions | 6.32e-06 | 24 | 103 | 4 | int:CACNA1D | |
| Interaction | SCN4B interactions | 7.13e-06 | 8 | 103 | 3 | int:SCN4B | |
| Interaction | PIGW interactions | 8.82e-06 | 26 | 103 | 4 | int:PIGW | |
| Interaction | TVP23C interactions | 9.82e-06 | 56 | 103 | 5 | int:TVP23C | |
| Interaction | VIPR1 interactions | 1.04e-05 | 205 | 103 | 8 | int:VIPR1 | |
| Interaction | SCN1A interactions | 1.39e-05 | 29 | 103 | 4 | int:SCN1A | |
| Interaction | SCN10A interactions | 2.08e-05 | 11 | 103 | 3 | int:SCN10A | |
| Interaction | B3GAT1 interactions | GINM1 FLVCR1 ARL6IP5 RRBP1 SLC30A4 SLC38A1 SLC7A1 SLC7A2 SLC9A1 SV2A | 2.35e-05 | 377 | 103 | 10 | int:B3GAT1 |
| Interaction | CACNA1B interactions | 3.73e-05 | 37 | 103 | 4 | int:CACNA1B | |
| Interaction | NEDD4L interactions | 3.89e-05 | 320 | 103 | 9 | int:NEDD4L | |
| Interaction | ARF6 interactions | FLVCR1 ARL6IP5 ABCC5 SLC7A6 DENND4C MSMB SLC38A1 SLC7A1 SLC7A2 SLC9A1 CADM1 EPHA7 | 4.34e-05 | 584 | 103 | 12 | int:ARF6 |
| Interaction | CCR6 interactions | 9.34e-05 | 89 | 103 | 5 | int:CCR6 | |
| Interaction | CPB2 interactions | 1.18e-04 | 19 | 103 | 3 | int:CPB2 | |
| Interaction | STX7 interactions | CYBRD1 FLVCR1 RRBP1 SLC30A4 DENND4C SLC38A1 SLC7A1 SLC7A2 SLC9A1 SV2A SLC22A4 SEMA6A | 1.37e-04 | 659 | 103 | 12 | int:STX7 |
| Interaction | C5AR1 interactions | 1.40e-04 | 154 | 103 | 6 | int:C5AR1 | |
| Interaction | RAB2A interactions | FLVCR1 ABCC5 SLC7A6 DENND4C SLC38A1 SLC7A1 SLC7A2 YIPF5 SLC9A1 TMEM70 EPHA7 | 1.53e-04 | 567 | 103 | 11 | int:RAB2A |
| Interaction | RHOD interactions | FLVCR1 ARL6IP5 ABCC5 RRBP1 SLC7A6 DENND4C SLC38A1 SLC7A1 SLC7A2 SLC9A1 SLC22A4 | 1.65e-04 | 572 | 103 | 11 | int:RHOD |
| Interaction | TMEM41B interactions | 1.85e-04 | 162 | 103 | 6 | int:TMEM41B | |
| Interaction | SSTR3 interactions | 1.86e-04 | 393 | 103 | 9 | int:SSTR3 | |
| Interaction | ABHD3 interactions | 1.86e-04 | 22 | 103 | 3 | int:ABHD3 | |
| Interaction | FITM2 interactions | 1.92e-04 | 310 | 103 | 8 | int:FITM2 | |
| Interaction | SPPL2B interactions | 1.95e-04 | 233 | 103 | 7 | int:SPPL2B | |
| Interaction | MFSD8 interactions | 2.36e-04 | 59 | 103 | 4 | int:MFSD8 | |
| Interaction | CACNA1C interactions | 2.68e-04 | 61 | 103 | 4 | int:CACNA1C | |
| Interaction | RHOH interactions | FLVCR1 ARL6IP5 ABCC5 SLC38A1 SLC7A1 SLC7A2 SLC9A1 SLC22A4 SEMA6A EPHA7 | 2.93e-04 | 512 | 103 | 10 | int:RHOH |
| Interaction | CD63 interactions | 2.99e-04 | 114 | 103 | 5 | int:CD63 | |
| Interaction | GP5 interactions | 3.23e-04 | 64 | 103 | 4 | int:GP5 | |
| Interaction | RAC3 interactions | FLVCR1 ARL6IP5 ABCC5 RRBP1 SLC38A1 SLC7A1 SLC7A2 YIPF5 SLC9A1 SLC22A4 EPHA7 | 3.24e-04 | 619 | 103 | 11 | int:RAC3 |
| Interaction | HS2ST1 interactions | 3.37e-04 | 117 | 103 | 5 | int:HS2ST1 | |
| Interaction | PIGO interactions | 3.43e-04 | 65 | 103 | 4 | int:PIGO | |
| Interaction | AGPAT2 interactions | 3.85e-04 | 67 | 103 | 4 | int:AGPAT2 | |
| Interaction | TMEM186 interactions | 4.31e-04 | 69 | 103 | 4 | int:TMEM186 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11q11 | 2.77e-06 | 40 | 111 | 4 | chr11q11 | |
| Cytoband | 11p15.5 | 2.01e-04 | 118 | 111 | 4 | 11p15.5 | |
| Cytoband | 1p36.1-p35 | 2.06e-04 | 9 | 111 | 2 | 1p36.1-p35 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q24 | 2.66e-04 | 127 | 111 | 4 | chr2q24 | |
| Cytoband | 2q24 | 3.14e-04 | 11 | 111 | 2 | 2q24 | |
| Cytoband | 11q24.2 | 4.91e-04 | 63 | 111 | 3 | 11q24.2 | |
| Cytoband | 2q24.3 | 6.80e-04 | 16 | 111 | 2 | 2q24.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11q24 | 1.23e-03 | 191 | 111 | 4 | chr11q24 | |
| Cytoband | 1q44 | 2.46e-03 | 110 | 111 | 3 | 1q44 | |
| GeneFamily | Solute carriers | SLC2A7 FLVCR1 SLC12A8 SLC46A1 SLC35G2 SLC15A3 SLC7A6 SLC30A4 SLC1A6 SLC2A2 SLC6A1 SLC38A1 SLC6A12 SLC7A1 SLC7A2 SLC9A1 SLC12A9 SLC26A7 SLC22A1 SLC22A4 SLC6A20 SLC5A12 SLC5A8 | 4.54e-19 | 395 | 86 | 23 | 752 |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 1.68e-18 | 9 | 86 | 8 | 1203 | |
| GeneFamily | Olfactory receptors, family 4 | 3.75e-04 | 129 | 86 | 5 | 151 | |
| GeneFamily | CD molecules|Tetraspanins | 5.11e-04 | 33 | 86 | 3 | 768 | |
| GeneFamily | Anoctamins | 9.82e-04 | 10 | 86 | 2 | 865 | |
| GeneFamily | Olfactory receptors, family 8 | 1.63e-03 | 49 | 86 | 3 | 155 | |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_DN | TM9SF1 DOLK ABCC5 SLC46A1 PTDSS2 SPPL2B SLC7A6 SLC38A1 TGFBR3 SLC9A1 PCDH19 CD151 CTNS | 4.23e-06 | 681 | 107 | 13 | M5314 |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_DN | TM9SF1 DOLK ABCC5 SLC46A1 PTDSS2 SPPL2B SLC7A6 SLC38A1 TGFBR3 SLC9A1 PCDH19 CD151 CTNS | 5.96e-06 | 703 | 107 | 13 | MM1055 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | ABCC5 SLC6A1 SLC38A1 CADM1 SV2A SCN1A PCDH19 SCN2A SLC22A4 SCN3A SCN8A SCN9A SV2C CACNA1I MARCHF1 TMEM255A | 1.06e-05 | 1106 | 107 | 16 | M39071 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_TM4SF4_POS_PENK_POS_NEURON_CELL | 1.11e-05 | 122 | 107 | 6 | M45802 | |
| Coexpression | GSE25123_WT_VS_PPARG_KO_MACROPHAGE_ROSIGLITAZONE_STIM_DN | 1.16e-05 | 186 | 107 | 7 | M7938 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HDA1 | OPRK1 SLC38A1 CADM1 SV2A SCN2A SCN3A SCN8A SCN9A SV2C MARCHF1 TMEM255A | 2.75e-05 | 584 | 107 | 11 | M39068 |
| Coexpression | YAMAZAKI_TCEB3_TARGETS_UP | 6.28e-05 | 166 | 107 | 6 | M1542 | |
| Coexpression | YOSHIMURA_MAPK8_TARGETS_UP | PTGER4 SLC1A6 ADCYAP1R1 OPRK1 MSMB TGFBR3 SLC6A12 SLC7A2 CADM1 SLC22A1 SCN3A SCN9A CD53 CACNA1H OR13C7 KIT | 6.28e-05 | 1281 | 107 | 16 | M1884 |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k-means-cluster#1_top-relative-expression-ranked_1000 | 4.89e-07 | 211 | 96 | 9 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k1_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#1_top-relative-expression-ranked_200 | 2.07e-05 | 36 | 96 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_200_k1 | |
| CoexpressionAtlas | dev gonad_e13.5_M_DevVasTestis_Flk_top-relative-expression-ranked_1000 | GINM1 PLXDC1 ARL6IP5 OR2T4 ABCA9 ABCB1 TGFBR3 PROKR2 CYYR1 CD53 SEMA6A ADGRE1 KIT TMEM255A | 2.62e-05 | 846 | 96 | 14 | gudmap_dev gonad_e13.5_M_gudmap_devVasTestis_Flk_1000 |
| CoexpressionAtlas | kidney_adult_RenalCapsule_k-means-cluster#4_top-relative-expression-ranked_1000 | 3.57e-05 | 136 | 96 | 6 | gudmap_kidney_adult_RenalCapsule_k4_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_1000 | PLXDC1 ADCYAP1R1 TGFBR3 SLC7A2 PROKR2 SLC26A7 SCN2A NCAPD2 CACNA1H SEMA6A KIT TMEM255A EPHA7 | 4.44e-05 | 773 | 96 | 13 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_1000 |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_top-relative-expression-ranked_1000 | HECTD4 ADCYAP1R1 TSPAN17 CADM1 SLC26A7 SCN2A SCN3A SCN9A SV2C KIT TMEM255A EPHA7 | 1.16e-04 | 734 | 96 | 12 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_1000 |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.52e-07 | 187 | 111 | 7 | 2d17408b3b5f09d135084fd7ccce98e6b5ca632b | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-stromal_related|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.59e-07 | 193 | 111 | 7 | f27e2be497745098b5269aa799dd3d5f62d78ba7 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-stromal_related-ICC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.59e-07 | 193 | 111 | 7 | 4ccf984baebbb13ae916727137ce593fda7514a2 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.78e-07 | 194 | 111 | 7 | 6ac759828c41ffa974ee82842162caa959351dd1 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.78e-07 | 194 | 111 | 7 | 5d0b0d8e96f0e0297a4dba70a05d87081a4eb323 | |
| ToppCell | PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.75e-06 | 157 | 111 | 6 | 552fd5d09bbe81f58404ec38166feb30fc84def5 | |
| ToppCell | Striatum-Neuronal-Inhibitory|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.75e-06 | 157 | 111 | 6 | c41ff3fe9de7187575114febfe9bd8733366fb8a | |
| ToppCell | PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.79e-06 | 166 | 111 | 6 | bb8135119dc37fdbba476599a56d368f422688dc | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Outer_Medullary_Collecting_Duct_Intercalated_Cell_Type_A|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.79e-06 | 166 | 111 | 6 | 6fe8db8d45177a78605681f22e04fa8d0594f2df | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.49e-06 | 171 | 111 | 6 | a4a2c5dc995589fbe3d4ca6ee1df888807e4ae34 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.97e-06 | 174 | 111 | 6 | a62531ebf16b32b249168dca11b870f63a8aa81c | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.13e-06 | 175 | 111 | 6 | 182e45f5c02214d6b9f317ff5dc43af8b42de978 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-neuro-epithelial|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.30e-06 | 176 | 111 | 6 | 2e1003dc373b14d27f0464d980453fdcfc1005f0 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2-Inh_L1-6_PVALB_SCUBE3_(Chandelier_1)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.30e-06 | 176 | 111 | 6 | 95d5a4fdff1b9c715636684d22e06f8727ac0e7a | |
| ToppCell | droplet-Lung-LUNG-30m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.84e-06 | 179 | 111 | 6 | bfc226bcf0b93525992344f968268a261d86fcbf | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.84e-06 | 179 | 111 | 6 | 8ce5000088b727783a0619baa16a2cd036d21f54 | |
| ToppCell | droplet-Lung-LUNG-30m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.84e-06 | 179 | 111 | 6 | 36ad18f52e175ab636ceaa3be81212fa362c96c1 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.84e-06 | 179 | 111 | 6 | d3438fed0d85d5ed5afa8ff820c45143d77b6c0d | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.63e-06 | 183 | 111 | 6 | f8b636391f752e379a5c5575fd898bdf0907a3b8 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.84e-06 | 184 | 111 | 6 | e2de27cee3ea80f9b7a9a7884ceceeaa67b3214a | |
| ToppCell | 3'-Adult-SmallIntestine-Epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.84e-06 | 184 | 111 | 6 | ed7a8e79e5723a5f5a03f542203d9e50bdef5f50 | |
| ToppCell | PCW_10-12-Immune_Lymphocytic-Immune_Lymphocytic_NK/ILC-im_ILC2_(21)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 6.84e-06 | 184 | 111 | 6 | 33db879e629821fb75684e60f8f0749cf9623bdd | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.05e-06 | 185 | 111 | 6 | a7dba7db79275884b2a93d8a16f2e0c739e71370 | |
| ToppCell | 3'-Adult-SmallIntestine-Epithelial-mature_enterocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.27e-06 | 186 | 111 | 6 | bdd9d3a432aab46e733469b362f0064d35c1ac49 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.27e-06 | 186 | 111 | 6 | 77592a6397b44b2b59a4fc39d7224dd95343efe6 | |
| ToppCell | 3'-Adult-SmallIntestine-Epithelial-mature_enterocytic-Enterocyte|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.50e-06 | 187 | 111 | 6 | 9042bd0f57213a51503d9df2e4dce3209b7772d3 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.50e-06 | 187 | 111 | 6 | a2bf958ea59c359a265bfa437d59315e1920cdd4 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.73e-06 | 188 | 111 | 6 | 4544552ebd67e9eb3e40d8511bb2b03a6e1178f8 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 7.73e-06 | 188 | 111 | 6 | b73e8a40393c3f656e2fcfe395a761b1f985c254 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.97e-06 | 189 | 111 | 6 | a9864873b19ab3e60acf11f288fa7275badc2e42 | |
| ToppCell | Endothelial-A-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 7.97e-06 | 189 | 111 | 6 | 04b565855f58ca0f343904d04be657b66e109076 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Artery|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.97e-06 | 189 | 111 | 6 | b028466fcd36fdeceec752e55a24286a1cd62ae4 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.97e-06 | 189 | 111 | 6 | e82211b9dc7540e7a183be2cbcfae39fdf503949 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.97e-06 | 189 | 111 | 6 | 532aaf02b364c5c4f58a2021c7c21d86df3875c9 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.21e-06 | 190 | 111 | 6 | 2f54da2bee411f8868348a4c37034184b8f58a89 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.21e-06 | 190 | 111 | 6 | 3b8d1e66ae68c1eee64095e75195d76d97e24026 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.21e-06 | 190 | 111 | 6 | 6ea9fa08bd97bedcb21d3654467e7f8dd74c8fd0 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.21e-06 | 190 | 111 | 6 | 56cc761e50fddfb5366391518b4d8e16589b6b42 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.21e-06 | 190 | 111 | 6 | b3bccf4dd95e986db3cee324a6737f5fcc22e8e5 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.21e-06 | 190 | 111 | 6 | 25d4b591f75c26e404a34c42f1742d580af6598d | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.21e-06 | 190 | 111 | 6 | a3c6eec6df052105ab78b7e3c78f94218d5912eb | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.21e-06 | 190 | 111 | 6 | dc655e4782aab274f0c9b6e36a5ce315e3a1a4b9 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.46e-06 | 191 | 111 | 6 | 7b386512284dfaa0e95358b28ee82632ee965e64 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Outer_Medullary_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.72e-06 | 192 | 111 | 6 | 0bb06738e1c3ec0c044a7ee61f6cf1d4781fb53c | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.72e-06 | 192 | 111 | 6 | f6ec683b2133b3095a1fcc06ca8605cf38f774b5 | |
| ToppCell | 11.5-Airway-Epithelial-Epithelial|Airway / Age, Tissue, Lineage and Cell class | 8.72e-06 | 192 | 111 | 6 | a77d3692ff02ef7e066a9bd9e22725055a25c4d4 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.72e-06 | 192 | 111 | 6 | 690b3d17c481159bc96b8bc7f6a66b51343ee858 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.98e-06 | 193 | 111 | 6 | 9f9eb241b0b82a6f12de6921c3acf6fed7cf65bb | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.98e-06 | 193 | 111 | 6 | 294cb5b580bb83fe0eb04f112d5507aac35d4d44 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.98e-06 | 193 | 111 | 6 | 605fc2a25ed6846fb283b2918cfed98df6039d6b | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-large_intestine_goblet_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.98e-06 | 193 | 111 | 6 | 6a9bce5064938b5b84ad57b4fd4a7841afe100c8 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.98e-06 | 193 | 111 | 6 | 3d3c45d5ff6f3396a1990615aae9fe176e799994 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.25e-06 | 194 | 111 | 6 | 52aebb0b563e2c2058e7f0554ae870e47692b163 | |
| ToppCell | Neuron-Postmitotic-Inhibitory_Neuron-MGE2|World / Primary Cells by Cluster | 9.25e-06 | 194 | 111 | 6 | b42fd64b0fb95434a9e4e6586f31d26114a4074b | |
| ToppCell | Neuron-Postmitotic-Inhibitory_Neuron-MGE2-10|World / Primary Cells by Cluster | 9.25e-06 | 194 | 111 | 6 | 81e7bc6516ab8d02ccd1c76a56a3533b788c27c8 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.25e-06 | 194 | 111 | 6 | bd06e2b8d8c06cddf2e4f58849b86e09013acae1 | |
| ToppCell | Nasal_Brush|World / Tissue, Lineage and Cell class of Lung Cells from 10X | 9.52e-06 | 195 | 111 | 6 | 7509b980b6b293df02bec619ef5b83a6c7b49c03 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.52e-06 | 195 | 111 | 6 | 3f8ed20ad17afe1545e574e5ca5fe33c3704c7f3 | |
| ToppCell | CV-Mild-0|Mild / Virus stimulation, Condition and Cluster | 9.52e-06 | 195 | 111 | 6 | 2ffb9a9b6143bb404fe454cd939b573252bba6e9 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.01e-05 | 197 | 111 | 6 | b8dc192fc98428bbb701cc2ea57fc8ad93397785 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_basal-Suprabasal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.04e-05 | 198 | 111 | 6 | 28ada093cec552262731194a04a4b9ff93186c3b | |
| ToppCell | moderate-Epithelial-Secretory|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.04e-05 | 198 | 111 | 6 | 7d96d7105a849c7280ce87bd76ce130ac47384fd | |
| ToppCell | Parenchymal-10x5prime-Stromal-Pericyte-Muscle_pericyte_systemic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.04e-05 | 198 | 111 | 6 | 0dc5806714fb3d3983e9d19fa7a108e93a8090ed | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.07e-05 | 199 | 111 | 6 | 1e693d7bb481bf03a943b460a69787229625d7b1 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_secretory|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.07e-05 | 199 | 111 | 6 | 7223f853335492ca617dbec3e4b6872a8a463a45 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_secretory-Secretory_Goblet|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.07e-05 | 199 | 111 | 6 | e03bdc7cb825e287f41b834ec6061d23c1c03b04 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.10e-05 | 200 | 111 | 6 | d0167f96314be78b6d867bbcc6e4396071d931b8 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-NMBR|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.10e-05 | 200 | 111 | 6 | 862db57d043bdf3cb059fbfc8b29bc1eafdf64ec | |
| ToppCell | Neuronal-Inhibitory-iA-iA_2(LAMP5)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.10e-05 | 200 | 111 | 6 | e90155498397524b812c46f2412320230b445bb6 | |
| ToppCell | Neuronal-Inhibitory-iA|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.10e-05 | 200 | 111 | 6 | 5ef4a3dc18a44292184a59ced916183c0699b01e | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-NMBR--L1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.10e-05 | 200 | 111 | 6 | a91345f268f13170c27309333603eb82400c9947 | |
| ToppCell | proximal-Endothelial-Bronchial_Vessel_1|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.10e-05 | 200 | 111 | 6 | d034bd210c87b704acf45f50d888497c8737011b | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.10e-05 | 200 | 111 | 6 | b68d212159b9d04866ba02ff55c35be247805eec | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-NMBR-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.10e-05 | 200 | 111 | 6 | d416a7be1a4e6232fb58a9687774da24821f1fdd | |
| ToppCell | proximal-3-Endothelial-Bronchial_Vessel_1|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.10e-05 | 200 | 111 | 6 | 0ff4185021ec84b57be13b28495e2f8a4d195eb6 | |
| ToppCell | proximal-Endothelial-Bronchial_Vessel_1-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.10e-05 | 200 | 111 | 6 | e4f6e0b9502eb531f28d605f9dbda6a72a9ed320 | |
| ToppCell | PND01-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_G2M|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.86e-05 | 142 | 111 | 5 | be63c48794a227ea55978524c0f5935342fc455e | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.96e-05 | 143 | 111 | 5 | 990844ca674d30b2924c74b45bed4fdfb8463fa7 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l20-23|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.06e-05 | 144 | 111 | 5 | e9d62f202f0fa8747961036ef0eafed91fe8a42f | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Dlk1_(Zona_Incerta,_ventral_part_(ZIV)_and/or_Lateral_hypothalamus_(LH))-|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 3.35e-05 | 73 | 111 | 4 | cfb3d5bbb1d2b6d228c2cfbdc14e6f70860fe1f2 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Dlk1_(Zona_Incerta,_ventral_part_(ZIV)_and/or_Lateral_hypothalamus_(LH))--|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 3.35e-05 | 73 | 111 | 4 | 23e4ed235e75c7cf2807bd0dda56be7744d0fca0 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Dlk1_(Zona_Incerta,_ventral_part_(ZIV)_and/or_Lateral_hypothalamus_(LH))|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 3.35e-05 | 73 | 111 | 4 | 93f1a39aeb4859c2d7c821ce0ebafb7b7a9d81d4 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Ntn1_Npy2r|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.48e-05 | 148 | 111 | 5 | 5e738522d4ad35e08bc4ff8c41b7bea38ec6ef95 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Plch2_Dock5|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.96e-05 | 152 | 111 | 5 | fed80b467ec9e30c7f98bed6cc4f8c583b715e9e | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Plch2_Dock5|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.62e-05 | 157 | 111 | 5 | 516903469756c5fabfdf56d7bd59b3bdd7b44e39 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.76e-05 | 158 | 111 | 5 | 84c0a215dabf697ada036c2b9592d0c61b5077de | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.90e-05 | 159 | 111 | 5 | b9d34b9ed8db798f5ea93c44b469cae499403cb8 | |
| ToppCell | droplet-Kidney-nan-3m-Myeloid-nan|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.90e-05 | 159 | 111 | 5 | bea6e96ba40ebfc1e38687bfa1c61fe227c5a84d | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Lsp1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.90e-05 | 159 | 111 | 5 | 0dccc4275b9b4f8554dd556da7218e130bff8fd1 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.20e-05 | 161 | 111 | 5 | 133b4fadb499e842c19f573f9cf09ce08c1d4813 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.20e-05 | 161 | 111 | 5 | 9466b8658244116f8d21f2f88fb8c2d184b1bdf2 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.20e-05 | 161 | 111 | 5 | cb177ca10d848d0e25399ab5ebfcde1071fb94c2 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.20e-05 | 161 | 111 | 5 | dccb61d5e17a8f1c6d1fc146ee389f567659a0f0 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.36e-05 | 162 | 111 | 5 | 96c6e94a10b124a1d25dcd705ec5aaa8609c1089 | |
| ToppCell | droplet-Bladder-nan-3m-Hematologic-leukocyte|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.52e-05 | 163 | 111 | 5 | 2f32a9ab0230fdca98ffa7fd59397301d50e4f30 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Lsp1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.52e-05 | 163 | 111 | 5 | bba830a302919c8b33f914a8839877fc21dd28a0 | |
| ToppCell | droplet-Bladder-nan-3m-Hematologic|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.52e-05 | 163 | 111 | 5 | 6c2967dee563295febe2adabf503d095cb911ccf | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.52e-05 | 163 | 111 | 5 | 8d17f44faf0549fe71a9a45f811f50d767275414 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Lamp5|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.68e-05 | 164 | 111 | 5 | 08819970174a3eb4eee8e1e675075828665b845e | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.68e-05 | 164 | 111 | 5 | d847d509bb1791638032ade6755d8164586b5bd5 | |
| Drug | Zonisamide | 1.87e-17 | 17 | 107 | 9 | DB00909 | |
| Drug | sodium | SLC2A7 ARL6IP5 SLC12A8 SLC46A1 SLC7A6 SLC1A6 SLC2A2 SLC6A1 SLC38A1 SLC6A12 SLC7A1 SLC7A2 SLC9A1 SLC12A9 SLC26A7 SCN2A SLC22A4 SCN3A SCN4A SCN5A SLC6A20 SCN9A CACNA1H SLC5A12 SLC5A8 | 1.31e-12 | 944 | 107 | 25 | CID000000923 |
| Drug | Sodium | 5.92e-09 | 84 | 107 | 8 | ctd:D012964 | |
| Drug | APETx1, Anthopleura elegantissima | 6.87e-09 | 6 | 107 | 4 | ctd:C475726 | |
| Drug | Tetrodotoxin | 3.15e-08 | 40 | 107 | 6 | ctd:D013779 | |
| Drug | lamotrigine | 7.62e-08 | 116 | 107 | 8 | CID000003878 | |
| Drug | N-(2-methyl-3-(4-(4-(4-(trifluoromethoxy)benzyloxy)piperidin-1-yl)-1,3,5-triazin-2-ylamino)phenyl)acetamide | 1.01e-07 | 3 | 107 | 3 | ctd:C561228 | |
| Drug | potassium | RNASEH2A SLC12A8 SLC1A6 SLC2A2 SLC38A1 SLC7A1 SLC7A2 SLC9A1 SLC12A9 SV2A SCN2A SCN3A SCN4A SCN5A SCN9A SV2C CACNA1I CACNA1H CNGA2 | 2.16e-07 | 1008 | 107 | 19 | CID000000813 |
| Drug | oxcarbazepine | 2.71e-07 | 30 | 107 | 5 | CID000034312 | |
| Drug | tetradotoxin | SCN11A ADCYAP1R1 OPRK1 SLC6A1 SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A CACNA1I CACNA1H | 8.27e-07 | 428 | 107 | 12 | CID000020382 |
| Drug | Scorpion Venoms | 1.34e-06 | 18 | 107 | 4 | ctd:D012604 | |
| Drug | gabapentin | 1.36e-06 | 169 | 107 | 8 | CID000003446 | |
| Drug | NSC7524 | 2.37e-06 | 182 | 107 | 8 | CID000005657 | |
| Drug | verapamil | ABCC5 ABCA9 ABCB1 SLC9A1 SLC22A1 SLC22A4 SCN3A SCN4A SCN5A SCN9A CACNA1I CACNA1H | 3.36e-06 | 490 | 107 | 12 | CID000002520 |
| Drug | 2,3,5,6-tetrafluoro-4-methylbenzyl (Z)-(1RS)-cis-3-(2-chloro-3,3,3-trifluoroprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate | 5.56e-06 | 8 | 107 | 3 | ctd:C489827 | |
| Drug | bumetanide | 6.60e-06 | 209 | 107 | 8 | CID000002471 | |
| Drug | AC1L1MOZ | 7.44e-06 | 27 | 107 | 4 | CID000031958 | |
| Drug | Mexiletine | 8.30e-06 | 9 | 107 | 3 | ctd:D008801 | |
| Drug | methanethiosulfonate | 9.24e-06 | 103 | 107 | 6 | CID004188587 | |
| Drug | phenytoin | 9.29e-06 | 219 | 107 | 8 | CID000001775 | |
| Drug | pyraclofos | 1.09e-05 | 106 | 107 | 6 | CID000093460 | |
| Drug | zonisamide | 1.09e-05 | 62 | 107 | 5 | CID000005734 | |
| Drug | tocainide | 1.15e-05 | 30 | 107 | 4 | CID000038945 | |
| Drug | AC1L1CQC | 1.38e-05 | 65 | 107 | 5 | CID000002012 | |
| Drug | Heptachlor | 1.42e-05 | 111 | 107 | 6 | ctd:D006533 | |
| Drug | mulberroside A | 1.62e-05 | 11 | 107 | 3 | ctd:C420606 | |
| Drug | 5-hydroxypropafenone | 1.92e-05 | 34 | 107 | 4 | CID000107927 | |
| Drug | flecainide | 2.12e-05 | 71 | 107 | 5 | CID000003355 | |
| Drug | glycylsarcosine | 2.16e-05 | 35 | 107 | 4 | CID000093131 | |
| Drug | Ranolazine | 2.19e-05 | 2 | 107 | 2 | DB00243 | |
| Drug | Phenytoin | 2.19e-05 | 2 | 107 | 2 | DB00252 | |
| Drug | Flecainide | 2.19e-05 | 2 | 107 | 2 | DB01195 | |
| Drug | mu-conotoxin KIIIA, Conus kinoshitai | 2.19e-05 | 2 | 107 | 2 | ctd:C502265 | |
| Drug | benzocaine | 2.70e-05 | 37 | 107 | 4 | CID000002337 | |
| Drug | sipatrigine | 2.70e-05 | 37 | 107 | 4 | CID000060803 | |
| Drug | tetralol | 2.79e-05 | 13 | 107 | 3 | CID000010747 | |
| Drug | bepridil | 2.92e-05 | 126 | 107 | 6 | CID000002351 | |
| Drug | ranolazine | 3.34e-05 | 39 | 107 | 4 | CID000056959 | |
| Drug | AC1L38YU | 3.57e-05 | 79 | 107 | 5 | CID000085196 | |
| Drug | Leucomisine [17946-87-1]; Up 200; 16.2uM; MCF7; HT_HG-U133A | 4.37e-05 | 199 | 107 | 7 | 3546_UP | |
| Drug | Niflumic Acid | 4.50e-05 | 42 | 107 | 4 | ctd:D009544 | |
| Drug | Chlorpheniramine | 5.40e-05 | 16 | 107 | 3 | ctd:D002744 | |
| Drug | pilsicainide | 6.46e-05 | 46 | 107 | 4 | CID000004820 | |
| Drug | spiradoline | 6.46e-05 | 46 | 107 | 4 | CID000005620 | |
| Drug | hydrazoic acid | 6.54e-05 | 17 | 107 | 3 | CID000024530 | |
| Drug | 1,3-dioxoisoindoline-5-carboxamide | 6.54e-05 | 3 | 107 | 2 | CID010679219 | |
| Drug | NSC652297 | 6.54e-05 | 3 | 107 | 2 | CID000092781 | |
| Drug | SureCN2398996 | 6.54e-05 | 3 | 107 | 2 | CID010220069 | |
| Drug | N-desmethylmethsuximide | 6.54e-05 | 3 | 107 | 2 | CID000092154 | |
| Drug | Ibogaine | 6.54e-05 | 3 | 107 | 2 | ctd:D007050 | |
| Drug | Mirex | 7.65e-05 | 48 | 107 | 4 | ctd:D008917 | |
| Drug | moricizine | 7.82e-05 | 18 | 107 | 3 | CID000034632 | |
| Drug | quindine | 7.99e-05 | 219 | 107 | 7 | CID000001065 | |
| Drug | diprafenone | 9.26e-05 | 19 | 107 | 3 | CID000071249 | |
| Drug | propafenone | 1.00e-04 | 98 | 107 | 5 | CID000004932 | |
| Drug | lacosamide | 1.05e-04 | 52 | 107 | 4 | CID000219078 | |
| Drug | Soybean Oil | 1.09e-04 | 20 | 107 | 3 | ctd:D013024 | |
| Drug | HCNs | 1.09e-04 | 20 | 107 | 3 | CID006857665 | |
| Drug | isradipine | 1.10e-04 | 100 | 107 | 5 | CID000003784 | |
| Drug | amiodarone | 1.10e-04 | 160 | 107 | 6 | CID000002156 | |
| Drug | Lidocaine | 1.30e-04 | 4 | 107 | 2 | DB00281 | |
| Drug | APETx2 protein, Anthopleura elegantissima | 1.30e-04 | 4 | 107 | 2 | ctd:C501880 | |
| Drug | Propofol | 1.30e-04 | 4 | 107 | 2 | DB00818 | |
| Drug | Fospropofol | 1.30e-04 | 4 | 107 | 2 | DB06716 | |
| Drug | methsuximide | 1.30e-04 | 4 | 107 | 2 | CID000006476 | |
| Drug | 7-hydroxymitragynine | 1.30e-04 | 4 | 107 | 2 | ctd:C482678 | |
| Drug | triamterene | 1.61e-04 | 58 | 107 | 4 | CID000005546 | |
| Drug | sarcolysin | 1.64e-04 | 172 | 107 | 6 | CID000004053 | |
| Drug | glutamate | ARL6IP5 SLC7A6 SLC1A6 ADCYAP1R1 OPRK1 ABCB1 SLC6A1 SLC38A1 SV2A SCN4A SCN9A CACNA1I CACNA1H SEMA6A | 1.65e-04 | 962 | 107 | 14 | CID000000611 |
| Drug | NSC740136 | 1.65e-04 | 109 | 107 | 5 | CID000003706 | |
| Drug | Probenecid | 1.72e-04 | 59 | 107 | 4 | ctd:D011339 | |
| Drug | riluzole | 1.75e-04 | 174 | 107 | 6 | CID000005070 | |
| Drug | 1-hydroxy-2-oxo-3,3-bis(2-aminoethyl)-1-triazene | 1.96e-04 | 61 | 107 | 4 | ctd:C105351 | |
| Drug | carbamazepine | 2.03e-04 | 179 | 107 | 6 | CID000002554 | |
| Drug | methylglucamine | 2.09e-04 | 62 | 107 | 4 | CID000004049 | |
| Drug | etiracetam | 2.09e-04 | 62 | 107 | 4 | CID000059708 | |
| Drug | AC1NT1AF | 2.15e-04 | 25 | 107 | 3 | CID005322157 | |
| Drug | Multicide | 2.15e-04 | 25 | 107 | 3 | CID000024365 | |
| Drug | L-Lysine | 2.17e-04 | 5 | 107 | 2 | DB00123 | |
| Drug | phensuximide | 2.17e-04 | 5 | 107 | 2 | CID000006839 | |
| Drug | AC1NSZ76 | 2.17e-04 | 5 | 107 | 2 | CID005320215 | |
| Drug | NSC671054 | 2.17e-04 | 5 | 107 | 2 | CID005357223 | |
| Drug | isoquercetrin | 2.17e-04 | 5 | 107 | 2 | CID005480505 | |
| Drug | AC1O7G5C | 2.17e-04 | 5 | 107 | 2 | CID006603942 | |
| Drug | Flunarizine | 2.17e-04 | 5 | 107 | 2 | DB04841 | |
| Drug | Phenylbutyrates | 2.22e-04 | 63 | 107 | 4 | ctd:D010654 | |
| Drug | mibefradil | 2.36e-04 | 64 | 107 | 4 | CID000060662 | |
| Drug | carboxymethylcellulose | 2.40e-04 | 118 | 107 | 5 | CID000024748 | |
| Drug | phenamil | 2.43e-04 | 26 | 107 | 3 | CID000004755 | |
| Drug | Pirmenolum | 2.43e-04 | 26 | 107 | 3 | CID000004853 | |
| Drug | Flecainide | 2.43e-04 | 26 | 107 | 3 | ctd:D005424 | |
| Drug | saxitoxin | 2.50e-04 | 65 | 107 | 4 | CID000037165 | |
| Drug | mexiletine | 2.66e-04 | 66 | 107 | 4 | CID000004178 | |
| Drug | disopyramide | 2.66e-04 | 66 | 107 | 4 | CID000003114 | |
| Drug | resiniferatoxin | 2.66e-04 | 66 | 107 | 4 | CID000104826 | |
| Drug | PbTx-1 | 2.72e-04 | 27 | 107 | 3 | CID006437089 | |
| Drug | nefopam | 2.72e-04 | 27 | 107 | 3 | CID000004450 | |
| Drug | procainamide | 2.81e-04 | 190 | 107 | 6 | CID000004913 | |
| Drug | carbimazole | 2.81e-04 | 67 | 107 | 4 | CID000031072 | |
| Drug | probenecid | 2.90e-04 | 123 | 107 | 5 | CID000004911 | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 9.47e-19 | 10 | 106 | 8 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 9.47e-19 | 10 | 106 | 8 | DOID:0080422 (implicated_via_orthology) | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 1.04e-17 | 12 | 106 | 8 | DOID:0060170 (implicated_via_orthology) | |
| Disease | epilepsy (implicated_via_orthology) | SCN11A SLC1A6 ABCB1 SV2A SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A | 1.84e-11 | 163 | 106 | 11 | DOID:1826 (implicated_via_orthology) |
| Disease | Infantile Severe Myoclonic Epilepsy | 1.10e-07 | 13 | 106 | 4 | C0751122 | |
| Disease | Epilepsy | 1.39e-07 | 109 | 106 | 7 | C0014544 | |
| Disease | Epilepsy, Cryptogenic | 5.23e-07 | 82 | 106 | 6 | C0086237 | |
| Disease | Awakening Epilepsy | 5.23e-07 | 82 | 106 | 6 | C0751111 | |
| Disease | Aura | 5.23e-07 | 82 | 106 | 6 | C0236018 | |
| Disease | anxiety disorder (implicated_via_orthology) | 1.09e-06 | 22 | 106 | 4 | DOID:2030 (implicated_via_orthology) | |
| Disease | Generalized Epilepsy with Febrile Seizures Plus | 3.73e-06 | 9 | 106 | 3 | C3502809 | |
| Disease | Myoclonic Astatic Epilepsy | 7.28e-06 | 11 | 106 | 3 | C0393702 | |
| Disease | Early Infantile Epileptic Encephalopathy 6 | 1.28e-05 | 2 | 106 | 2 | C4551549 | |
| Disease | B Virus Infection | 3.83e-05 | 3 | 106 | 2 | C0037140 | |
| Disease | Benign familial infantile epilepsy | 3.83e-05 | 3 | 106 | 2 | cv:C5575231 | |
| Disease | Postherpetic neuralgia | 3.83e-05 | 3 | 106 | 2 | C0032768 | |
| Disease | Herpesviridae Infections | 3.83e-05 | 3 | 106 | 2 | C0019372 | |
| Disease | Primary Erythermalgia | 3.83e-05 | 3 | 106 | 2 | C0014805 | |
| Disease | PAROXYSMAL EXTREME PAIN DISORDER | 3.83e-05 | 3 | 106 | 2 | C1833661 | |
| Disease | trefoil factor 1 measurement | 1.90e-04 | 6 | 106 | 2 | EFO_0021865 | |
| Disease | Epilepsy, Generalized | 1.90e-04 | 6 | 106 | 2 | C0014548 | |
| Disease | Familial benign neonatal epilepsy | 1.90e-04 | 6 | 106 | 2 | C0220669 | |
| Disease | Seizure, Febrile, Simple | 2.65e-04 | 7 | 106 | 2 | C0149886 | |
| Disease | Seizure, Febrile, Complex | 2.65e-04 | 7 | 106 | 2 | C0751057 | |
| Disease | Congenital Pain Insensitivity | 2.65e-04 | 7 | 106 | 2 | C0002768 | |
| Disease | Hereditary Sensory Autonomic Neuropathy, Type 5 | 2.65e-04 | 7 | 106 | 2 | C0020075 | |
| Disease | alanine measurement | 2.66e-04 | 86 | 106 | 4 | EFO_0009765 | |
| Disease | Early Childhood Epilepsy, Myoclonic | 3.53e-04 | 8 | 106 | 2 | C0393695 | |
| Disease | Idiopathic Myoclonic Epilepsy | 3.53e-04 | 8 | 106 | 2 | C0338478 | |
| Disease | Symptomatic Myoclonic Epilepsy | 3.53e-04 | 8 | 106 | 2 | C0338479 | |
| Disease | Benign Infantile Myoclonic Epilepsy | 3.53e-04 | 8 | 106 | 2 | C0751120 | |
| Disease | Myoclonic Encephalopathy | 3.53e-04 | 8 | 106 | 2 | C0438414 | |
| Disease | Myoclonic Absence Epilepsy | 3.53e-04 | 8 | 106 | 2 | C0393703 | |
| Disease | butyrylcarnitine measurement | 3.53e-04 | 8 | 106 | 2 | EFO_0020010 | |
| Disease | Neurodevelopmental Disorders | 3.59e-04 | 93 | 106 | 4 | C1535926 | |
| Disease | Febrile Convulsions | 4.53e-04 | 9 | 106 | 2 | C0009952 | |
| Disease | X-11381 measurement | 4.53e-04 | 9 | 106 | 2 | EFO_0021228 | |
| Disease | Myoclonic Epilepsy | 4.53e-04 | 9 | 106 | 2 | C0014550 | |
| Disease | Epilepsy, Myoclonic, Infantile | 5.65e-04 | 10 | 106 | 2 | C0917800 | |
| Disease | apolipoprotein B measurement | 6.55e-04 | 663 | 106 | 9 | EFO_0004615 | |
| Disease | metabolite measurement | 9.49e-04 | 560 | 106 | 8 | EFO_0004725 | |
| Disease | dihomo-linolenoylcarnitine (C20:3n3 or 6) measurement | 9.72e-04 | 13 | 106 | 2 | EFO_0800547 | |
| Disease | HOMA-B | 1.03e-03 | 55 | 106 | 3 | EFO_0004469 | |
| Disease | Withdrawal Symptoms | 1.20e-03 | 58 | 106 | 3 | C0087169 | |
| Disease | Drug Withdrawal Symptoms | 1.20e-03 | 58 | 106 | 3 | C0086189 | |
| Disease | Substance Withdrawal Syndrome | 1.20e-03 | 58 | 106 | 3 | C0038587 | |
| Disease | MMR-related febrile seizures | 1.30e-03 | 15 | 106 | 2 | EFO_0006519 | |
| Disease | Early infantile epileptic encephalopathy with suppression bursts | 1.48e-03 | 16 | 106 | 2 | C0393706 | |
| Disease | cholangiocarcinoma (is_marker_for) | 1.60e-03 | 64 | 106 | 3 | DOID:4947 (is_marker_for) | |
| Disease | ulcerative colitis (is_implicated_in) | 1.68e-03 | 17 | 106 | 2 | DOID:8577 (is_implicated_in) | |
| Disease | Febrile seizure (within the age range of 3 months to 6 years) | 1.88e-03 | 18 | 106 | 2 | HP_0002373 | |
| Disease | renal cell carcinoma (is_implicated_in) | 1.99e-03 | 69 | 106 | 3 | DOID:4450 (is_implicated_in) | |
| Disease | end stage renal disease (implicated_via_orthology) | 2.33e-03 | 20 | 106 | 2 | DOID:783 (implicated_via_orthology) | |
| Disease | asthma, response to diisocyanate | 2.56e-03 | 261 | 106 | 5 | EFO_0006995, MONDO_0004979 | |
| Disease | epilepsy (biomarker_via_orthology) | 2.57e-03 | 21 | 106 | 2 | DOID:1826 (biomarker_via_orthology) | |
| Disease | docosahexaenoic acid to total fatty acids percentage | 2.57e-03 | 21 | 106 | 2 | EFO_0022262 | |
| Disease | total iron binding capacity | 2.82e-03 | 78 | 106 | 3 | EFO_0006334 | |
| Disease | amino acid measurement | 3.13e-03 | 678 | 106 | 8 | EFO_0005134 | |
| Disease | Drug toxicity | 3.48e-03 | 84 | 106 | 3 | C0013221 | |
| Disease | Adverse reaction to drug | 3.48e-03 | 84 | 106 | 3 | C0041755 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DTGAMVFVVFGIIGV | 1006 | Q9P2K9 | |
| TLGNVFVIVGSIIMV | 51 | P19397 | |
| FVIVGSIIMVVAFLG | 56 | P19397 | |
| PVLMVTGFVFIQGIA | 51 | Q53TN4 | |
| VIILVLGIVGFMFGS | 76 | Q8NHY0 | |
| SAQIVVLTGFVMVFT | 291 | Q8IUA7 | |
| GVLAVIANGMVIAFT | 606 | A1A5B4 | |
| VLLFVMVAGFVKGNV | 201 | P52569 | |
| TQIIHIGAFQGMVSI | 36 | P0CG01 | |
| LVFSAVVFGAMAVGQ | 976 | P08183 | |
| VFVIGLAGNSMVVAI | 51 | Q9NPB9 | |
| GSIAGILFVTMIFVA | 686 | Q8TAB3 | |
| VIGGFNMVATSLTII | 201 | Q8NGM9 | |
| SVGLMGIVVGTVFII | 226 | P01906 | |
| MVIFVNIGLVASGCF | 196 | Q8NGN6 | |
| NVISMGVTNVIFLGV | 196 | P0DN81 | |
| FVYIATVGGNMLIVV | 31 | Q8NGM1 | |
| THIFGLMVVINSGFI | 191 | Q8NGM1 | |
| FNILGMVVFAFATIT | 341 | Q96NT5 | |
| VVTVVGNLGMIFLIA | 36 | Q9GZM6 | |
| GIVVAATGMAVALFS | 111 | Q9UPQ8 | |
| GVFTQFVMSKVGALQ | 1536 | Q8IWI9 | |
| GFINIFPMINTTVFV | 311 | P10721 | |
| ATMVFINVVGVVVTF | 376 | Q8N468 | |
| MTEVFVIVGVFLAQI | 171 | Q6PXP3 | |
| TAIAGIVFGIVFIMG | 61 | Q96J86 | |
| IVFGIVFIMGVIAGI | 66 | Q96J86 | |
| PVFFQFLNIMVVGIT | 261 | Q9NU53 | |
| FLNIMVVGITGAAVV | 266 | Q9NU53 | |
| FSNEVMIVVSALGVG | 191 | Q8NHC7 | |
| AMIGGFVHSVVQIVF | 146 | Q8NH70 | |
| VVIFVVFLMALSGNA | 61 | Q8NH00 | |
| VTIPAVMFIFGVVGN | 21 | P35408 | |
| VMFIFGVVGNLVAIV | 26 | P35408 | |
| ATIGVGAVNMVFTAV | 341 | P11168 | |
| GAVNMVFTAVSVFLV | 346 | P11168 | |
| VAVIVVAIMSSGIFV | 56 | Q9GIP4 | |
| GVQVMFSGLIFSVEV | 5036 | P98088 | |
| EMIIQFGFVTLFVAS | 731 | Q5XXA6 | |
| VNMDVNFPGAAFVVV | 2581 | Q9Y4D8 | |
| MNVLLGSVVIFATFV | 1 | P08118 | |
| VAVAGTIILVFMVFG | 561 | Q15375 | |
| VLVGVLAMAFTASIG | 111 | P46089 | |
| LVVVAIGFTGGLVFM | 201 | Q8TCQ1 | |
| GPVVGSIMVNFVLFI | 311 | P41586 | |
| MGVFTYVLVLGVAAV | 206 | Q9Y6A1 | |
| NVILVFFCVGMIAGV | 996 | O15440 | |
| VIGGVVAVVVFAMLC | 376 | Q9BY67 | |
| IFTRSVVEVGFMIGQ | 161 | P57773 | |
| LIVSFFVLNMFVGVV | 1416 | Q9P0X4 | |
| AVLTGVAEAVVAMIF | 426 | Q5VZ89 | |
| LVVFSVAFGLVIGGM | 271 | P48664 | |
| IIVFVTGGVLGFFMT | 426 | Q9Y5Y0 | |
| LFAFVTMIVAAVGVT | 246 | O60931 | |
| VGIGIACVQVFGMIF | 226 | P48509 | |
| IVSFFVLNMFVGVVV | 1541 | O95180 | |
| LTSLVTMAFVFVGQV | 366 | A0AV02 | |
| TMAFVFVGQVNVLAP | 371 | A0AV02 | |
| FFGFTSVIVAGVLEM | 416 | Q8IY34 | |
| GTVLVNAVSGVLMAF | 181 | O15245 | |
| FTVLFVIVGMGQISN | 196 | Q9H015 | |
| VIVGMGQISNYVVAF | 201 | Q9H015 | |
| AIGSVIVGVTGFMAF | 831 | Q3KNS1 | |
| VEMTVFFSAGFNIIV | 211 | Q8NGG7 | |
| DVSFNVMIIFAVGGL | 191 | Q15619 | |
| VMVLAGAVSVLVGAF | 196 | A4D2G3 | |
| GIGLGMAIVQVTSVF | 151 | Q5JRS4 | |
| VVGLVGNSLVMFVII | 71 | P41145 | |
| AMIGGFVHSAFQIVV | 146 | Q8NH83 | |
| AVVFNGGAICMVIFT | 196 | P0C604 | |
| HFFGGVEIILLVVMA | 126 | Q8NGB2 | |
| IFFIHVVGGVEMVLL | 101 | Q6IEY1 | |
| STGSIIEFIFGVVMF | 466 | Q8WU17 | |
| FVEVSFAGQMGRTTV | 281 | Q2WGJ9 | |
| IIVAGVFIFSAVQMT | 506 | P30531 | |
| ALMADGVEVFVVGFV | 161 | Q496J9 | |
| TVGNLVFTGIFTAEM | 611 | P35499 | |
| VFIFAVVGMQLFGKS | 711 | P35499 | |
| QGVNVTQVFVDTVGM | 131 | O75792 | |
| RQMLVASIVFISFGV | 86 | Q5JRV8 | |
| MQGQLRVVVATVAFG | 761 | O94761 | |
| FGGVIIMISVFVLAG | 376 | Q8TBE7 | |
| MILGGIVVVLVFTGF | 66 | O75915 | |
| LVFFVNVGGVAMREI | 351 | Q9BVG9 | |
| VVFSILGFMSQEQGV | 336 | P48065 | |
| VGNLVFTGIFTAEMT | 751 | Q14524 | |
| IVFIFAVVGMQLFGK | 876 | Q15858 | |
| VVFAGMLVISAAIGI | 16 | Q8N695 | |
| FQVGIMVAGFASVII | 191 | Q8N695 | |
| IIVFIFAVVGMQLFG | 891 | Q9NY46 | |
| GVGVASVVVSFFLSM | 86 | Q9NP91 | |
| LMADGVEVFVVGFVL | 176 | Q7L0J3 | |
| TVGNLVFTGIFTAEM | 801 | P35498 | |
| VFIFAVVGMQLFGKS | 901 | P35498 | |
| TGVAFVSFVGMESVL | 476 | Q14246 | |
| VMVFQFGVPQALFGV | 661 | Q15021 | |
| VLIFATIVGNVGSMI | 361 | Q16280 | |
| VGIFMFGISTEEIVS | 491 | Q7RTR0 | |
| LFVVVGGVMSVLGFA | 66 | Q96FV3 | |
| TQTLGVVVFGGFMVV | 6 | Q9P2E9 | |
| VVVFGGFMVVSAIGI | 11 | Q9P2E9 | |
| GFMVVSAIGIFLVST | 16 | Q9P2E9 | |
| VVSGVAIFVNVGMVV | 286 | Q96AN5 | |
| INVLVLGFIMVSGFV | 196 | P30825 | |
| ILAFVMGAVFSGITV | 656 | Q9H2E6 | |
| ASFAVVIMVTVLGVV | 606 | Q9NXL6 | |
| MFSIVVFLRIGFVVG | 51 | Q9BXP2 | |
| VIIFIMAVGTVAIGG | 176 | Q8TCT7 | |
| IVFIFAVVGMQLFGK | 891 | Q99250 | |
| TVIFFTVFVQGMTIR | 486 | P19634 | |
| VFIFAVVGMQLFGKS | 886 | Q9UQD0 | |
| AGIMLVCGIGNFVFI | 61 | Q8NFJ6 | |
| FIFGVEFVGPVVTMT | 226 | Q8NFJ6 | |
| SFAVIFSLQGMVGII | 196 | Q969M3 | |
| AQIIVMGVQVVGRAF | 6 | Q9Y3D7 | |
| VSLVVGNMIGSGIFV | 51 | Q92536 | |
| TAAVGVAVNVIMGFL | 221 | O14863 | |
| VIFIFSVVGMQLFGR | 711 | Q9UI33 | |
| ITIATGGFIFMGDVI | 151 | Q8IUK5 | |
| QIIFYGIMGSFTVIT | 141 | Q9BUB7 | |
| VSFLGGVIQVAMFVL | 151 | Q8TE54 | |
| VMIVGFLTVLIQGST | 191 | Q1EHB4 | |
| DIFGVVGVTSANMLI | 416 | Q9H2H9 | |
| TVMGIAFAAFVIGAL | 786 | Q03167 | |
| NSMVLVFLLVGFVAV | 241 | O15321 | |
| QGTIIALVVVMAFSV | 766 | Q9Y2G1 |